The Union faculty and staff are ready to help you design courses and curriculum to meet your specific training needs. With expertise in the clinical, programmatic, and organisational management of diseases, our team has designed programmes for some of the leading lung health organisations in the world.
Here you can find out more about the experts who run our courses.
Faculty

Dr Tara Bouton
Dr. Tara C. Bouton is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine of Boston University and an attending physician in the Section of Infectious Diseases at Boston Medical Center. Dr. Bouton’s research focuses on the impact of HIV infection and substance use on evolution and transmission of drug resistant tuberculosis and improving outcomes in these diseases. She is also working to better understand transmission and viral dynamics of SARS-CoV-2 variants. She has lived and worked in Brazil, Ghana, Botswana, and South Africa.

Dr Miranda Brouwer
Dr Miranda Brouwer is a public health medical doctor with over 20 years’ experience in clinical medicine and public health, and in supporting tuberculosis and HIV programmes. She is an analytical thinker with a practical approach to problem solving. She is able to make complex (medical) material understandable for all levels. She is a calm, flexible and reliable person with a good sense of humour, and focused to meet the objectives, and has strong abilities in planning, organising and monitoring.

Dr E. Jane Carter
Dr E. Jane Carter has dedicated her career to tuberculosis. She is both an Associate Professor of Medicine at Brown University, USA, and Director of the Brown Kenya Medical Exchange Programme at Moi University, Kenya. In Rhode Island she worked with the Department of Health sponsored TB Clinic for over 22 years. She is a past president of The Union. In recognition of her global health work, she was awarded the World Lung Health Award from the American Thoracic Society in 2013. Her TB work has focused on active case finding in resource limited areas as well as improving the care cascade for paediatric care and prevention.

Sheilla Chebore
Sheilla Chebore has a master's degree in medical microbiology and is currently doing a PhD. Sheilla has over 20 years’ experience in the field of laboratory science, working in diagnostic clinical settings, research settings and public health programmatic settings both in public, international agencies and non-profit organizations. Sheilla also has over 10 years’ experience in public health programmatic settings with extensive knowledge in TB, HIV, AMR and COVID 19 laboratory diagnostics. She has supported and consulted for the Kenyan National Tuberculosis Lung and Disease Programme (NTLD-P) and national public health laboratories.

Dr Chen-Yuan Chiang
Dr Chen-Yuan Chiang is a clinician specialising in respiratory and critical care medicine. He is a member of the Core Group of Global Drug-Resistant TB Initiative, the TB Technical Advisory Group of WHO Western Pacific Region, the Regional GLC in the Western Pacific, and the Technical Review Panel, Global Fund to Fight AIDS, Tuberculosis and Malaria. He is Associate Professor, Department of Internal Medicine, Taipei Medical University. He is the Course Director of the international course on Clinical and Programmatic Management of DR-TB.

Dr Riitta Dlodlo
Dr Riitta Dlodlo has worked in both clinical and programmatic TB, TB-HIV and management of health services and projects for over 30 years in Zimbabwe and other sub-Saharan African countries. She joined The Union in 2003 and held various roles. Riitta coordinates the development of Union publications, leads and develops content for Union courses and provides advice in all aspects of TB. She is the course director of the Principles of TB Care and Prevention: Translating Knowledge to Action.

Dr Steve Graham
Steve Graham has served as a senior consultant in child tuberculosis and lung health for The Union since 2008. He is a paediatrician with over 20 years’ experience in clinical and operational research and training in tuberculosis and pneumonia in both the African and Asia-Pacific regions. Steve is currently based at the University of Melbourne and The Burnet Institute in Australia.

Dr Anthony D. Harries
Anthony David Harries is Senior Advisor at The Union and an honorary professor at the London School of Hygiene and Tropical Medicine in the UK. He is a physician and registered specialist in the UK in infectious diseases and tropical medicine. He spent over 20 years living and working in sub-Saharan Africa. His main interests are in the field of tuberculosis, HIV/AIDS, non-communicable diseases, tropical medicine and operational research.

Dr Einar Heldal
Einar Heldal was with the national TB programme in Nicaragua, a model programme for DOTS development, from 1987 to 1990. He was the head of the TB registry in Norway from 1994-2005. Since then, Einar has been an independent TB consultant, part time with the Norwegian Institute of Public Health. He has extensive international experience in TB programme support and reviews, long-term in Russia, East Timor and Zimbabwe. Einar worked with WHO and many non-governmental organisations, especially in recording and reporting, use of routine TB data for management, operational research, MDR-TB, LTBI, ethics, migration, and prison health. He has published on TB epidemiology, TB mortality and BCG vaccination.

Dr Stephen John
Dr Stephen John has been active in TB, Leprosy and HIV control in Nigeria since 2003, having served as a TB Programme Manager and an HIV Agency Executive Secretary. Stephen is currently a Health Ministry Director of Planning, Research and Statistics. Stephen has served as a trainer at the National TB and Leprosy Training Center Zaria, Nigeria, a mentor to State TB and Leprosy Programme Managers and a university teacher. He has been a consultant for several organisations and is presently serving as a technical consultant to the United Nations Office for Project Services.
Stephen is a graduate of Medicine, has a Master of Public Health/International Course in Health Development and a has Professional Diploma in Education. Dr Jhon serves as a member of the Board of Directors of The Union.

Dr Kobto Ghislain Koura
Dr Kobto Ghislain Koura is a medical epidemiologist. He has participated in the management of international projects and his work over these years has focused on diseases, including malaria and anaemia, in low-income countries. He also completed a post doctorate in epidemiology at Claude Bernard University in Lyon, France. Since joining The Union in 2013, his work has focused on technical assistance, operational research and education, addressing the challenges of tuberculosis in Francophone African countries. He also serves as faculty member in several courses in France and he is associated researcher to MERIT Laboratory, a laboratory of The IRD (Institut de Recherche pour le Développement), a French research organism.

Dr Ajay Kumar
Dr Ajay Kumar is a seasoned Public Health Practitioner with over 24 years of experience in low- and middle-income settings. He currently leads the Centre for Operational Research of the International Union Against Tuberculosis and Lung Disease. In the past, he has worked for WHO-India as a consultant for providing technical assistance to the Government of India’s National Tuberculosis Programme, particularly in leading TB-HIV co-ordination activities. He is an author/co-author of over 250 publications, with many contributing to a change in policy/practice and has facilitated over 100 national and international courses on operational research.

Dr Rebecca Lin
Rebecca Chou-Jui Lin is a pulmonologist working in Taoyuan General Hospital, Ministry of Health and Welfare and one of the lead physician of the five MDRTB teams in Taiwan. She had also participated in the DRTB workshop and technical assistance in Vietnam and the Philippines. Over the years, her patients had taught her how to appreciate simple but important things in life: a genuine smile, a few kind words, and a cup of good coffee, from which we can all find courage to move on.

Dr C. Patricia Macias
Dr C. Patricia Macias has worked for The International Union since 2014 as a faculty member for several Union TB courses. She is the Medical Director for the Tuberculosis Unit at The Cook County Department of Public Health in the Chicago area of Illinois. She is dedicated to providing care to the immigrant and disadvantaged population of the region. She is a full time Physician at the Cook County Health and Hospitals System, where she works as an Academic Pulmonary Doctor.

Nqobile Mlilo
Nqobile Mlilo is the monitoring and evaluation specialist at The Union Zimbabwe Trust. He provides technical support to the Zimbabwe National TB Control Program and has been working in the field of public health monitoring and evaluation of TB/HIV programs for 19 years.

Dr Ignacio Monedero
Dr Ignacio Monedero is a medical doctor specialised in family and community medicine. He has been involved in NGO projects in developing countries, especially in tropical and infectious diseases. He has worked in more than 35 countries providing technical assistance, MDR-TB and TB-HIV trainings and supporting operational research projects. He has been involved in the writing of several Union guidelines, including TB-HIV and MDR-TB, in addition to different MDR-TB papers.

Dr Divya Nair
Divya Nair is an Operational Research Fellow at The Union. She is a medical doctor with post graduate degree in Community Medicine. She has close to a decade’s experience of designing and managing community-based multi-site multi-partner research projects related to epidemiology, public health and policy research. She is trained in Good Clinical Practices and regulatory guidelines governing the ethical conduct of biomedical and clinical research in India.

Dr Moorine Sekadde
Dr Moorine Penninah Sekadde is a paediatrician and public health expert with more than 15 years of experience in clinical care, capacity building, research, design and implementation of public health interventions. Her current focus area is child and adolescent TB including aspects of integration within Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCAH). She is a core team member on the WHO child and adolescent TB technical work group as well as a WHO STAG-TB member.

Dr Tafadzwa Priscilla Sibanda
Tafadzwa Priscilla Sibanda is a Public Health Specialist with a decade of experience in the health sector in Zimbabwe. She has worked through the various levels of health services from an intern at a tertiary hospital to positions at the district level for four years and MCH/TB/HIV programme manager at the provincial level for four years. Tafadzwa has been involved in both clinical and programme management, as well as monitoring and evaluation of these programs.

Dr Pranay Sinha
Dr Pranay Sinha is an Infectious Diseases physician and an Assistant Professor of Medicine at Boston University. He has been involved in TB research since 2014 and his primary interest is in the relationship between undernutrition and TB. Through epidemiological studies & health economic modelling, he hopes find ways to use nutritional policy to end TB. Dr Sinha has field experience in India, Benin, Togo, and South Africa.

Annika Sweetland
Annika Sweetland is a social worker and Assistant Professor of Clinical Sociomedical Sciences in Psychiatry at Columbia University College of Physicians and Surgeons/Mailman School of Public Health. She is also Co-Founder and Co-Chair of the TB and Mental Health Working Group at The Union. For the past 20 years, she has conducted global mental health work in Latin America, Africa and the United States, with a topical focus on TB and depression.

Dr Pruthu Thekkur
Pruthu Thekkur is a Senior Operational Research Fellow at the Centre for Operational Research (COR) at The Union. He is a medical doctor with MD in Community Medicine. He has a decade’s experience in leading multiple operational research projects in collaboration with various national governments, research institutes, and international NGOs in the South-East Asia and Africa region. He is a senior mentor for Structured Operational Research Training Initiative (SORT IT) and has mentored about 50 public health professionals from more than 15 countries.

Dr Mahalakshmy T
Dr Mahalakshmy T is a medical doctor and currently teaches at the Jawaharlal Institute of Postgraduate Medical Education and Research, in Puducherry, India. She has expertise in epidemiology, qualitative research, medical education research and operational research. She is pursuing her fellowship in Health Policy and Systems Research. She has around 10 years of experience in designing and mentoring public health research projects for MD and MPH students. Her areas of interest are cancer epidemiology, adolescent health and tuberculosis.

Collins Timire
Collins Timire is a Senior Operational Research Fellow at The Union, seconded to the National TB Programme, Zimbabwe. He recently completed a PhD at the London School of Hygiene & Tropical Medicine, UK. In addition, he holds a Master of Public Health and a Bachelor of Medical Laboratory Science. Collins is adept at both qualitative and quantitative research methods. Collins has more than 60 publications in peer reviewed journals, and is a recipient of the New Zealand Development Scholarship and the Fogarty Fellowship, National Institute of Health, USA.

Dr Elizabeth Yarly
Dr Yarly is a dedicated advocate for individual interests within complex systems, bringing invaluable expertise in capacity development, coaching, and leadership enhancement. With a robust background as an Organizational Development consultant, she has successfully facilitated people-centered initiatives globally for over fifteen years. Her role as faculty focuses on crafting content that drives sustainable structural change, particularly in the domains of Global Health and Education.
Dr Stella Zawedde-Muyanja
Stella Zawedde-Muyanja is a medical doctor and research scientist based at the Infectious Diseases Institute, College of Health Sciences, Makerere University, Uganda. Her primary research focus is implementation research to improve delivery of and access to TB care services. While working with the Union Uganda, she led the pilot implementation of a project to decentralize child TB services in Uganda (the DETECT Child TB project). Dr. Zawedde-Muyanja has worked with the Uganda NTLP on a number of initiatives to improve provision of TB care services.
Union staff and consultants
Mrs Lara Garrido-Herrero, Director of Training and Education
Mrs Caroline Bennett, eLearning Coordinator
Dr Sandy Picken, Instructional Designer
Training to protect the world from disease
Working in a strategic partnership with the CDC, The Union developed the CDC IMPACT Program, a robust and comprehensive training program to help boost the management and leadership skills of public health fellows in Bangladesh, Cambodia and Kenya.
Programme management to improve patient outcomes
Union Courses delivered training to improve project management and budgeting skills to a diverse team of healthcare and administrative professionals. They could then better assist the Ministry of Health in Myanmar and have a meaningful impact on the state of TB and TB-HIV in the country.
Building capacity for effective tobacco control efforts
As part of The Bloomberg Initiative to Reduce Tobacco Use program, Union Courses built the management and leadership skills of potential grantees to ensure the success of grassroots efforts and deliver maximum impact at the local level.
Giving advocates tools to fight noncommunicable diseases
The Union facilitated a strategic sessions that allowed representatives from national NCD organisations to better understand how to define shared priorities and visioning as an advocacy network.
World Lung Cancer Day 2020: Respiratory groups stress lung cancer risks and importance of early screening and treatment
In support of World Lung Cancer Day, the Forum of International Respiratory Societies calls for more awareness and understanding of lung cancer risk factors, as well as the importance of early screening and treatment.
The Union congratulates India’s Ministry of Health and Family Welfare for adopting measure to prevent tobacco industry interference in health policy
The Code of Conduct, effective from 6 July 2020, restricts officials and staff from collaborating with the tobacco industry.
The Union says FDA decision to allow Philip Morris to market IQOS will have devastating consequences for non-smokers and young adults
The Union criticised the decision by the U.S. FDA to allow Philip Morris International to market its IQOS heated tobacco product as a 'modified risk tobacco product'.
Respiratory groups call for stronger measures to protect young people from tobacco industry marketing
On World No Tobacco Day the Forum of International Respiratory Societies, of which The Union is a founding member, calls on governments and policymakers to implement stronger measures to protect teenagers and adolescents from tobacco industry marketing.
The Union advocates for the banning of e-cigarettes and heated tobacco product sales in low- and middle- income countries
On World No Tobacco Day the International Union Against Tuberculosis and Lung Disease (The Union) advocates for the banning of e-cigarettes and heated tobacco product sales in low- and middle- income countries.
COVID-19 and Clinical Distancing
Negative pressure helmet and tent devices developed by the University of Michigan could transform COVID-19 patient treatment and protect health care workers. Studies on the two innovative new devices published today in the IJTLD.
The COVID-19 pandemic must not divert attention from the needs of children and adolescents in TB-endemic African countries
Union warns that if resources are diverted away from child and adolescent TB programmes in order to fight COVID-19, the consequences could be devastating
Statement on World Health Organization funding
The Union expressed its indignation at the decision by US President Trump to announce the suspension of its funding of the World Health Organization.
The Union’s statement on COVID-19 and Smoking
The Union is deeply concerned about COVID-19’s impact on the world’s 1.3 billion smokers and the low- and middle-income countries whose health systems are plagued by tobacco-related disease.
World TB Day Statement on CEPHEID rapid testing for COVID-19
CEPHEID rapid testing for COVID-19 designed to operate on any of Cepheid's more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes.
COVID-19 in focus on World TB Day
The Union stands in solidarity and with resilience in the fight against two airborne diseases: TB and COVID-19
The Union Celebrates 15th Anniversary of the FCTC
José Luis Castro discusses key accomplishments, new challenges in tobacco epidemic
Study by The Union shows longterm effectiveness for shortened DR-TB treatment regimen up to 24 months after treatment completion
Results from a Union-led observational study show that a nine-month shortened treatment regimen for RR-TB delivered to patients under programmatic conditions maintains a good level of effectiveness up to 24 months after completion.
The Union welcomes WHO recommendations for treatment of drug-resistant tuberculosis
The Union welcomes the rapid communication from the World Health Organization on the treatment of drug-resistant tuberculosis.
The Union welcomes new and updated Global Plan to End TB 2018–2022
The Union today welcomed the STOP TB Partnership's updated Global Plan to End TB 2018-2022, launched today in Jakarta, Indonesia
Union response to the WHO 2019 Global Tuberculosis Report
Statement from The Union on the World Health Organization Global Tuberculosis Report 2019
Actress Claire Forlani announced as ambassador for The Union ahead of the Union World Conference on Lung Health
Actress Claire Forlani announced as ambassador for the International Union Against Tuberculosis and Lung Disease ahead of the 50th Union World Conference on Lung Health to be held in Hyderabad, India
Making Tobacco Control A Priority to Achieve Lung Health
A joint press release to mark World No Tobacco Day 2019 was made by the Framework Convention Alliance and The Union
The Union congratulates the Government of Brazil for its efforts to hold the tobacco industry legally liable for the harm it causes
The Union today welcomed the filing of a lawsuit by the Government of Brazil against British American Tobacco (BAT) and Philip Morris International (PMI)
50th Union World Conference on Lung Health launched in Hyderabad ahead of World TB day.
Some 6000 delegates – political leaders, doctors, researchers, nurses, celebrities and activists – expected to attend the four day event
STREAM clinical trial results prove that a nine-month treatment regimen for MDR-TB is as effective as the 20-month regimen
Final results are released today in the New England Journal of Medicine and just ahead of World TB Day on 24 March
Appointment of former tobacco industry director as Deputy Minister of Commerce in the Turkish Government must be revoked
The Union calls for the Turkish Government to revoke the appointment of Mr Riza Tuna Turagay – a Director of British American Tobacco until January 2019 – as Deputy Minister of Commerce by Presidential decree.
Hitting tuberculosis for six (in Hindi)
HINDI version: Cricket tournament and summit to pledge support for a TB free India by 2025
Hitting tuberculosis for six
Top Indian parliamentarians to participate in cricket tournament and summit to pledge support for a TB free India by 2025
Ending The Emergency
The 50th Union World Conference On Lung Health comes to India, the country with the world’s highest tuberculosis burden
Tuberculosis at the crossroads: human rights and TB science under the spotlight at the 49th Union World Conference on Lung Health to be held in The Hague
More than 3500 researchers, policy makers and advocates will gather at the World Forum in The Hague, The Netherlands 24-27 October.
New operational research finds TB patients diagnosed through active case finding suffer less financial costs
Research led by researchers from The Union South-East Asia Office has been published in Global Health Action journal
The Union Statement on UN HLM on TB
The International Union Against Tuberculosis and Lung Disease expresses its disappointment at the no-show of European Heads of State attending the first ever United Nations High-Level Meeting on Tuberculosis in New York on Wednesday September 26.
The Union applauds presence of Japanese PM Shinzo Abe at UN HLM
The Union Against Tuberculosis and Lung Disease applauds the confirmation of Japanese Prime Minister Shinzo Abe at the first ever United Nations High-Level Meeting on Tuberculosis on Wednesday September 26.
Groundbreaking studies prompt The Union to urge global leaders to scale up commitment to TB prevention and treatment
Results from two new studies show that TB medicine rifampin offers less toxic, shorter, more tolerable treatment option for latent tuberculosis (TB), representing a potential paradigm shift for TB prevention around the world.
On World Lung Cancer Day, FIRS commemorates, celebrates and supports those impacted by lung cancer
On World Lung Cancer Day, 1 August 2018, The Union, alongside members of the Forum of International Respiratory Societies (FIRS) commemorate, celebrate and support those impacted by lung cancer.
New Report Exposes Silent Epidemic of Child TB
The Union published a new report today, “Silent Epidemic: A Call to Action Against Child Tuberculosis”, calling for urgent action to protect children from tuberculosis
Largest ever whole-of-population study on the impact of TB and HIV interventions on the burden of TB launched in sub-Saharan African communities
A new EUR 12.9 million project has been launched, measuring the impact of a combination TB and HIV intervention when delivered to the entire population of 14 urban, high prevalence communities in South Africa and Zambia.
Forum of International Respiratory Societies calls on governments for political commitment and action to end TB
On World TB Day, the Forum of International Respiratory Societies calls on the United Nations General Assembly to commit to the urgent changes needed to end tuberculosis, in their first High-Level Meeting (HLM) on TB.
The City of The Hague to light up iconic landmarks for World TB Day
The Hague, The Netherlands, will join cities across the globe emblazoning its landmarks in red to mark World TB Day on 24 March and to shine a light on the city as the host for the 49th Union World Conference on Lung Health in October.
Guide to delivering high quality care for TB patients launched (PDF 115 KB)
On Universal Health Coverage Day updated guide supports front line staff to offer quality health care to every TB patient around the world
Dr Tedros Adhanom Ghebreyesus, Dr Aaron Motsoaledi and Michael R. Bloomberg to attend WCTOH (PDF 170 KB)
The World Conference on Tobacco or Health is to be held in Cape Town, South Africa, 7-9 March 2018.
World COPD Day, November 15, 2017: A Look at the Many Faces of COPD (PDF 87 KB)
In support of World COPD Day, FIRS joins patients, health care professionals, nonprofit organisations, and government agencies in coming together today to take action against one of the world’s most prevalent respiratory diseases.
World Pneumonia Day on November 12, 2017 (PDF 52 KB)
In support of World Pneumonia Day, 12 November, the Forum of International Respiratory Societies (FIRS) calls for global efforts to stop pneumonia and strengthen strategies to protect, prevent and treat pneumonia.
STREAM clinical trial results provide vital insight into nine-month treatment regimen for multidrug-resistant tuberculosis (PDF 87 KB)
Preliminary results from Stage 1 of the STREAM randomised clinical trial show that the nine-month treatment regimen being tested achieved favourable outcomes in almost 80 percent of those treated.
Wirelessly Observed Therapy could revolutionise tuberculosis treatment, researchers to tell the 48th Union World Conference on Lung Health in Guadalajara, Mexico, 11-14 October, 2017 (PDF 60 KB)
A range of new technological advances in the diagnosis and treatment of tuberculosis to be unveiled for the first time in Guadalajara.
The Union welcomes the WHO's recognition of TB alongside other pathogens as priority for R&D
The Union welcomes the WHO’s Priority Pathogen Report, released today, highlighting drug-resistant tuberculosis (DR-TB) as a priority for research and development in the battle against AMR.
Breakthrough research linking diabetes and TB infection to be announced at the 48th Union World Conference on Lung Health in Guadalajara (PDF 153 KB)
Conference to be opened by the Mexican Secretary of Health, Dr José Narro Robles and feature address by H.E. Dr Tabaré Ramón Vázquez Rosas, President of Uruguay
The Union welcomes major finance firms’ pledge of public support for tobacco control
On World No Tobacco Day, The Union welcomes the announcement from 53 leading finance firms that today affirmed their public support for international efforts to reduce tobacco use under the WHO FCTC.
Forum of International Respiratory Societies (FIRS) issues five key points, critical to addressing tuberculosis epidemic (PDF 125 KB)
In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS) urges action on five united strategies to ensure the aim of ending tuberculosis (TB) by 2030 becomes achievable, despite new and emerging challenges.
The 48th Union World Conference on Lung Health in Guadalajara, Mexico launched ahead of World TB Day (PDF 93 KB)
Mexican footballer Andrés Guardado announced as Conference Ambassador - The 48th Union World Conference on Lung Health, to be held at the Expo Guadalajara Convention Centre in Guadalajara, Mexico, on 11-14 October this year
Statement from The International Union Against Tuberculosis and Lung Disease (The Union) on Bedaquiline access, India (PDF 281 KB)
Drug-resistant TB is one of the most terrible diseases that any person can ever face. The health system must do everything in its power to provide access to effective treatments for every patient.
World Health Organization Framework Convention on Tobacco Control, 7th Conference of the Parties Begins in New Delhi, India (PDF 236KB)
Tobacco use is still the greatest preventable cause of death worldwide. It claims more than six million lives each year. In total it is projected to kill up to one billion people this century unless there is a coordinated and sustained intervention.
An innovative new tool to assess the sustainability of national tobacco control programmes launched by The Union
The Index of Tobacco Control Sustainability (ITCS) has been launched by the International Union Against Tuberculosis and Lung Disease (The Union) to assist countries to assess and guide national tobacco control programmes to become sustainable.
Natural Disasters and Weak Health Systems Force Innovative Approaches to Delivering Tuberculosis Treatment and Care: Studies
New research announced today demonstrates the innovation needed to maintain tuberculosis (TB) treatment and care in the face of natural disasters and weak health systems.
New Links Found Between Tuberculosis and Non-communicable Diseases
A series of new research announced today demonstrates linkages between tuberculosis (TB), an infectious disease, and non-communicable diseases including chronic kidney disease and diabetes.
Research Finds Promise in Shorter, More Effective Approaches to Treating Drug-Resistant Tuberculosis (PDF 346 KB)
With improper treatment, drug-resistance can develop quickly. Health clinics are missing opportunities to diagnose drug-resistant TB sooner, studies show.
New research was presented at the 47th Union World Conference on Lung Health.
Breakthrough study demonstrates far shorter, more effective treatment for multidrug-resistant tuberculosis (MDR-TB), with majority cured (PDF 334KB)
Final results demonstrated nine-month treatment had 82% success rate, compared with previous standard that required more than 20 months of treatment and achieved cure rates below 55%
47th Union World Conference on Lung Health Announces “Community Common” Programme Highlights (PDF 97KB)
Highlights include Mini-Football Tournament and Live Open Fire Display of New Clean Cook-stove Technology That Can Reduce Deadly Childhood Pneumonia
High rate of patients cured of multidrug-resistant tuberculosis in landmark study: final results to be announced at the 47th Union World Conference on Lung Health (PDF 99KB)
The conference will be held in Liverpool, United Kingdom, 26-29 October, 2016
Experts Call for Action Against Food- and Animal-borne Tuberculosis (PDF 166 KB)
Public call made in advance of the 47th Union World Conference on Lung Health
Mexico will host the 48th World Conference on Lung Health (PDF 110KB)
The conference will be held in Guadalajara, in the state of Jalisco, from 11-14 October 2017
WHO report underscores action needed against TB and diabetes
Summit in Bali positioned to make decisive headway against the looming co-epidemic
Health officials urge action against TB and diabetes
Bali summit marks first major effort to mount defense against looming co-epidemic
Liverpool to host the 47th Union World Conference on Lung Health
Attracting more than 3,000 delegates from 125 countries
The Union to Host 45th Union World Conference on Lung Health
Conference to be held 28 October – 1 November in Barcelona, Spain. Confirmed speakers include UK member of Parliament Nick Herbert MP, CDC Director Dr Thomas Frieden, Global Fund Executive Director Dr Mark Dybul
20 years of key Operational Research and its impact on TB care and control in India
This landmark compilation documents policy decisions and practices driven by OR evidence.
Forum of International Respiratory Societies to assist in finding the 3 million “missed” TB cases
Download the FIRS press release
Challenges of ending drug-resistant tuberculosis (DRTB) the focus of Special Edition of the International Journal of Tuberculosis and Lung Disease (IJTLD)
Drug-resistant TB (DRTB) continues to be a public health threat and is one of the leading antimicrobial resistant infections globally. Worldwide in 2019, close to half a million people developed DRTB. However, only 38 per cent of people with DRTB started treatments and of those treated, only 57 per cent were treated successfully.
Prevent Tuberculosis: Management of TB Infection
The Union developed an online course in English, French and Spanish to improve the knowledge regarding all aspects of TB infection care, including diagnosis and treatment with the aim of increasing country-level implementation of TB Infection care.
BASIC OCCUPATIONAL SAFETY AND HEALTH FOR RESPIRATORY DISEASES
subtitle: a desk guide for health facilities
Specialized training in clinical and programmatic management of DR-TB
In September 2022, The Union delivered the first national DR-TB clinical and programmatic course in the country and was founded by the Global Fund TB Grant for Eritrea.
Management of Child and Adolescent TB - Training of Trainers
A blended format training that supports cascading of training on the Management of Child and Adolescent TB by national and sub-national trainers in TB high-burden countries.
RFP for Human Resources Information System
Request for Proposal (RFP) floated to hire an Agency for providing Human Resources Information System (HRIS).
The Union is soliciting proposals from qualified and experienced HRIS vendor to provide a single, robust integrated enterprise HRIS solution across all countries. The Union intends to deploy the HRIS globally to ensure data management and efficient operations.
Proposal submission deadline: 15 April 2025
Smokefree Implementation
Smokefree laws accomplish three goals: they protect the public from second-hand smoke exposure; they motivate quit efforts (cessation); and they improve indoor air quality.
Assessment of Factors that Influence Implementation of Tobacco Use Treatment Viet Nam
Application of the Consolidated Framework for Implementation Research (CFIR) to assess factors that may influence implementation of tobacco use treatment guidelines in the Viet Nam public health care delivery system.
Examples of Smokefree Hospital Guides
This is a set of smokefree hospital strategic guides to equip those implementing smokefree policies with the tools for effective implementation and enforcement.
Examples of Tobacco Control Strategic Plans
Examples of tobacco control strategic plans to provide guidance for creating comprehensive implementation and enforcement agendas, yearly plans and public health goal setting.
Case Study: PMI Involvement in Smoking Cessation
This article is a case study ion Philip Morris' involvement in the cessation arena and an evaluation of how and why PM supports cessation programs. It illustrates a notable example of industry interference that undermines effective tobacco control.
African Tobacco Control Alliance (ACTA) - Industry Watch
The African Tobacco Control Alliance (ATCA) is a Pan-African network of more than 120 civil society organizations that monitors and responds to industry interference and provides regional resources. This page provides case studies of African countries and organizations responding to tobacco industry interference.
African Tobacco Industry Monitoring
The Africa Centre For Tobacco Industry Monitoring And Policy Research (ATIM) is an observatory that offers up-to-date information on activities and developments in the tobacco industry that could have an impact on tobacco control policies. ATIM provides industry monitoring across Africa, as recommended by the Guidelines for implementation of Article 5.3 of the WHO FCTC, evaluates the impact of tobacco control policy, and informs stakeholders within the tobacco control community of ongoing developments.
STOP Crooked 9: Nine ways the Tobacco Industry Undermines Health Policy
The Crooked Nine report outlines the tobacco industry's strategies, techniques, and tactics to undermine tobacco control using case studies from around the world. It is designed to help the tobacco control community predict the industry's actions and counter industry interference.
Campaign for Tobacco-Free Kids Industry Watch
The Campaign for Tobacco-Free Kids Industry Watch project seeks to hold the tobacco industry accountable by providing facts about how tobacco companies operate and working to expose and stop the industry’s harmful activities. The Industry Watch website contains helpful resources, including factsheets, industry profiles, reports and studies, presentations, press releases, and key websites.
The Economic Impact of Clean Indoor Air Laws
This article reviews and analyses the diffusion of clean indoor air laws and the economic and public health impacts of their implementation. While research sponsored by the tobacco industry has raised concerns regarding the economic impact of smoke-free laws, scientific evidence indicates that clean indoor air laws are low-cost, safe, and effective.
Exposing and Addressing Tobacco Industry Conduct in LMICs
This article explores the tobacco industry's practices in low and middle-income countries (LMICs), given the industry's growing interest, investment, and interference in these regions. It focuses on how exposing the industry's misconduct is necessary for both the implementation of the WHO FCTC and more 'endgame' solutions to the tobacco epidemic.
Health is Non-Negotiable: Civil Society Against Tobacco Industry Strategies in Latin America
This report compiles case studies with the aim of exposing the tobacco industry's strategies for blocking tobacco control efforts and disseminates information on the counter efforts of four civil society organizations in Argentina, Brazil, Colombia, and Mexico.
Global Tobacco Industry Interference Index, 2019
This report uses publicly available information on tobacco industry interference in 33 countries and their respective governments’ responses to these interferences to interpret key findings and rank the countries on several interference indicators.
Observatory on Strategies of the Tobacco Industry in Brazil
This website offers detailed information and data on the tactics used by the tobacco industry in Brazil, the legislative measures Brazil is adopting to meet FCTC and WHO directives, and the people and organizations involved with the tobacco industry that lobby against tobacco control measures in Brazil. The website is available in English, Portuguese, and Spanish.
Policy Dystopia Model Interpretive Analysis of TI Political Activity
This article outlines a model that provides an evidence-based summary of corporate political strategies used by the tobacco industry. The model enables public health practitioners to anticipate these strategies and develop realistic assessments of the industry’s claims.
Stopping Tobacco Organizations and Products - A Global Tobacco Industry Watchdog
Stopping Tobacco Organizations and Products (STOP) works to understand and expose the tobacco industry’s efforts to derail tobacco control and hook a new generation of users. STOP's Resources Archive arms and supports stakeholders with tools and resources to counter the industry, including the latest analyses, reports, and information on the industry’s tactics.
The ‘‘We Card’’ Program: Tobacco Industry ‘‘Youth Smoking Prevention’’ as Industry Self-Preservation
This article analyzes the tobacco industry self-regulation "We Card" program. It exposes "We Card" as ineffective and structured to improve the industry's public image and limit tobacco control policies and their enforcement.
Tobacco Industry Youth Smoking Prevention Programs: Protecting the Industry and Hurting Tobacco Control
This article analyzes tobacco industry documents to determine why industry-sponsored youth smoking prevention programs were developed, how they were used to fight tobacco control policy and programming, and their lack of effect on youth smoking prevalence.
Tobacco Tactics: The essential source for rigorous research on the tobacco industry
Tobacco Tactics investigates tobacco industry strategies and tactics for undermining tobacco control efforts and provides rigorously researched reports, profiles, and information on industry players, allies, and activities.
Tobacco Unmasked
Tobacco Unmasked is the information portal of the Centre for Combating Tobacco in Sri Lanka. It provides information and profiles on tobacco companies, their employees, their allies, and other institutions linked with them. The portal also describes industry strategies and arguments against tobacco control efforts.
Tobacco Control Industry Watch - Southeast Asia Tobacco Control Alliance
Tobacco Control Industry Watch provides facts and figures, publications, and media updates for the South East Asian Tobacco Control Alliance (SEATCA). With a focus on Articles 5.3 and 13, guidelines, toolkits, and in-country statuses are also available to further the effective implementation of the WHO FCTC in ASEAN countries.
UCSF Truth Tobacco Industry Documents Database
The University of California San Francisco database contains over 14 million archived documents on tobacco industry activities, including advertising, manufacturing, marketing, scientific research, and political activities. In particular, the database provides access to internal industry documents made public during United States v. Philip Morris USA Inc., et al. and other litigation cases.
Vector of the Tobacco Epidemic Tobacco Industry Practices in LMICs
This article reviews published research on tobacco industry activities that interfere with tobacco control policies and encourage tobacco use in LMICs to more thoroughly understand industry practices and strategies in LMICs.
WHO FCTC Guide on How to Conduct Industry Monitoring
Tobacco industry interference remains the most significant barrier to the global implementation of Article 5.3 of the WHO FCTC. This guide aims to assist parties in their efforts to implement and protect tobacco control efforts from tobacco industry interference.
WHO 2008 Tobacco Industry Interference with Tobacco Control
This document aims to provide background and contextual information on tobacco industry interference practices and how Contracting Parties to the WHO FCTC can monitor industry interference efforts and better implement FCTC Article 5.3 guidelines.
Evidence to guide action comprehensive tobacco control in Ontario 2016
An example of a research synthesis to inform tobacco control policy and strategy. This report from Ontario, Canada, provides a comprehensive assessment of the tobacco control interventions that would have the greatest impact on reducing tobacco use and its associated burden in Ontario.
Examples of Smokefree Implementation Protocols
Examples of smokefree protocols to support the implementation of smokefree policies.
Smokefree Air: Law Enforcement Lessons from the Field
This toolkit from the Global Smokefree Partnership draws on the experience of jurisdictions that have successfully implemented strong smokefree laws, and captures some of the important lessons common to these efforts.
Index of Tobacco Control Sustainability
A tool to measure the sustainability of national tobacco control programmes. Includes a report of tobacco control sustainability assessments from 24 countries with the world’s highest tobacco burden.
Program Sustainability Framework and Assessment Tools
Set of tools for program sustainability including a self assessment guide and a program framework guide.
WHO Report on the Global Tobacco Epidemic, 2013
This report, WHO’s fourth in the series, provides a country-level examination of the global tobacco epidemic and identifies countries that have applied selected measures for reducing tobacco use. This report focuses on Enforcing bans on tobacco advertising, promotion and sponsorship.
Enforcement of and compliance with tobacco control legislation: A guide for the AFRO region
This guide from the WHO Regional Office for Africa provides useful tools for all those involved in promoting enforcement of, and compliance with, tobacco control legislation.
Enforcement of Tobacco Control Law: A Guide to the Basics
This booklet provides an overview of key smokefree enforcement issues and sources of more information- because the authors live in Bangladesh this booklet draws heavily on examples from that country, but most of the issues are universal and approaches should easily be adaptable.
WHO FCTC Implementation Guidelines
This publication contains the guidelines adopted by the Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (WHO FCTC) at its second (2007), third (2008), fourth (2010) and fifth (2012) sessions.
Tobacco Control Delivery Plan: England 2017-2022
An example of a national delivery and monitoring plan. Published in conjunction with the Tobacco Control Plan for England, it identifies lead agencies, milestones and metrics to measure success.
Explaining Mechanisms that Influence Smoke-free Implementation at the Local Level
Study that analyzes existing smokefree evidence and translates it into recommendations to improve smokefree implementation in outdoor venues.
Implementing smoke-free policies in low- and middle-income countries: A brief review and research agenda
A review and research agenda on the challenges of implementing smokefree policies in low- and middle-income countries, identifying five areas where progress is urgently needed.
WHO: Making Cities Smokefree, 2011
This WHO publication offers practical guidance to assist staff and city officials prepare for and implement smokefree legislation.
CDC Indicators for Eliminating Exposure to Secondhand Smoke, 2017
This report is the third in the CDC's publications on Evaluating Comprehensive Tobacco Control Programs and provides an evaluation logic model and set out outcome indicators that address eliminating exposure to secondhand smoke.
China Subnational Smokefree Law Predictors
This study analyzes the predictors of adopting subnational smokefree laws since China ratified the WHO FCTC in 2005 and assess their alignment with article 8.
Compliance Surveys: Smokefree compliance tools in India
This article demonstrates how smokefree compliance can be assessed through simple and cost-effective survey tools and can be used to validate implementation and enforcement progress.
Evaluation of Compliance to Gutka Ban & Other Provisions of COTPA India
This article uses a random sampling process to evaluate compliance with the COPTA legislation in India.
Compliance Evaluation of San Francisco's Flavoured Tobacco Sales Prohibition
This research assesses compliance with San Francisco's 2018 flavored tobacco sales ban and concludes that retailer education prior to enforcement will result in higher compliance rates.
Evaluation of Enforcement Barriers in Minnesota Youth, 2002
This report evaluates the enforcement practices, and barriers of the Commercial Youth Access Enforcement efforts in Minnesota, USA, providing recommendation for future enforcement efforts.
Evidence on the Effect of POS Display Bans on Smoking Prevalence
This study evaluates the effect of point-of-sale display bans globally as of 2016.
Indicators to Measure Success of Smoke-free Policies
This article assess indictors of smokefree policy implementation in the Unites States, New Zealand, and Israel to demonstrate successful compliance of smokefree policies.
Global Evidence Review on the Implementation and Effectiveness of TC Measures
This report reviews the global evidence on the impact of the WHO FCTC implementation of tobacco control legislation.
Mixed-methods Evaluation TAPS ban in Banyuwangi, Indonesia
This policy evaluation reviews the outdoor tobacco advertisement ban in Banyuqangi District East Java, Indonesia.
Evaluation of the Impact of Smokefree Law, New Zealand
The aim of this evaluation is to identify outcomes related to the 2003 Smokefree Environments Amendment Act and assess how closely goals were met.
Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda
This paper proposes a general working taxonomic of eight implementation elements to measure implementation outcomes, advance implementation processes, and improve effectiveness of implementation strategies.
Perceived Enforcement of Smokefree in Brazil
The aim of this study is to evaluate the perceived enforcement of anti-smoking legislation on 4 Brazilian cities.
POS Tobacco Advertising and Display Bans in 5 Russian Cities
This study aims to evaluate the implementation of national TAPS law in kiosks across five Russian cities.
Retailer licensing and tobacco display compliance, Australia
This study aims to assess vendor licensing compliance and scheme to explore variations in compliance among different retailer types and locations.
Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014
This study aims to evaluated the global progress of the six MPOWER measures and their impact across 88 countries that have adopted one or more measure from 2007 to 2014.
Review of Compliance Strategies for Enforcing SF policy
Comprehensive literature review to provide evidence for effective enforcement strategies and suggest measures to improve policy compliance.
Evaluation of Smoking-related Deaths Averted Due to Three Years of Policy Progress, 2013
This study aims to determine the number of smoking-attributable deaths were averted due to the implementation of MPOWER policies.
Assessment of EU Member State National Characteristics and Their Association with Smoking Prevalence
This study aims to assess public sector corruption and other national characteristics and it's potential association with higher smoking prevalence in EU member states.
WHO FCTC Global Progress Report, 2018
The 2018 global progress report on the implementation of WHO FCTC.
Community Perception of Smokefree Policy in Depok City, Indonesia
This study analyzes the perception of smokefree policy within a university community service program and finds that while many people are aware of smoking's harmful effects, they do not know about smokefree policies, highlighting the need for community education, effective communication, and engagement.
Guide for Smokefree Law, England
This document is England's official guide on their 2007 smokefree law. It is directed towards managers responsible for complying with the smokefree law in workplaces and public places.
WHO FCTC Tobacco Control Glossary 2015 Edition
This WHO FCTC glossary defines terms used in the FCTC and its instruments. It can be used for educational purposes and to aid a better understanding of the FCTC.
Case Study: Effective Translation of the Framework Convention in Mexico
This case study describes the impact of the sociocultural and political-economic context of Mexico on WHO-FCTC policy uptake. It examines advancing tobacco control policy through strategic, contextually-specific communication efforts and uses smokefree policy to illustrate barriers to compliance in the Mexican context.
Curbing the Epidemic: governments and the economics of tobacco control, 1999
This report analyzes how economic fear influences policymakers when contemplating tobacco control efforts. It also demonstrates the economic benefits of tobacco control policies and the responsibility of governments to reduce potential costs of tobacco control efforts.
British Columbia 100% Smokefree: Successful Campaign Despite Industry Opposition
This article describes how the British Columbia Capital Regional District systematically organized an educational campaign, enacted and enforced a series of bylaws, exposed industry interference to successfully pass and implement a 100% smokefree bylaw in all public places.
Examples of Information Materials for Businesses
Collection of example flyers and leaflets from tobacco control initiatives around the globe for different venues types, including restaurants, sports clubs, government buildings, tobacco retailers and more.
ENFORCING Strong SMOKE-FREE Laws: The Advocate’s Guide to Enforcement Strategies
This guide examines specific barriers to the enforcement of smokefree laws and regulations and offers proven advocacy strategies for overcoming these barriers.
NYC food Establishment Self-Inspection Worksheet
This self-inspection checklist for food establishments by the NYC Bureau of Food Safety and Community Sanitation provides a checklist (on page 2, part 2) that covers compliance with various regulations, including smokefree, product regulation, and POS.
FDA Compliance and Enforcement Report
Report on the last five years of the FDA Center for Tobacco Products Office compliance and enforcement activities.
Assessing Compliance with Smokefree Laws 2nd Edition
This guide promotes best practice for conducting studies of compliance with smoke-free laws, including the rationale for doing or not doing a study, the knowledge and resources needed, and how to design the study and effectively disseminate the results. Available in English and Spanish.
THE UNION TOOLKIT FOR WHO FCTC ARTICLE 5.3
The Union’s FCTC Article 5.3 Toolkit provides step-by-step guidance for governments on preventing tobacco industry interference and protecting tobacco control laws and policies.
Countering Tobacco Tactics
"Countering Tobacco Tactics" is a guide to help policymakers and tobacco control advocates identify, monitor, expose, challenge, and counter tobacco industry tactics in order to prevent industry interference in public health and health policy.
Assessing Compliance with TAPS Bans
A “How-to” Guide for Observing the Internet, Sponsored Events, and Corporate Social Responsibility.
Assessing Compliance with Health Warning Labels
This Guide provides steps and sample materials to assess compliance with health warning labels,
Compliance with Smoke-free Public Places, Depok, Indonesia, 2019
This study from Depok City, Indonesia, assessed compliance with smokefree in different settings from February to March 2019.
Compliance with Tobacco Product Display and Point-of-Sale TAPS, Depok, Indonesia 2019
This study from Depok City, Indonesia, assessed compliance with the tobacco product display and point-of-sale advertising and promotion ban in different retail settings from February to March 2019.
Compliance with Smoke-free Public Places, Yogyakarta, Indonesia, 2019
This study from Yogyakarta City, Indonesia, assessed compliance with smokefree in different settings from February to March 2019.
Compliance with Smoke-free Public Places, East and South Districts of Karachi, Pakistan, 2019
This study from Karachi, Pakistan, assessed compliance with smokefree in different settings from October to November 2019.
Compliance with Smoke-free Public Service Vehicles, East and South Districts of Karachi, Pakistan, 2019
The objective of this study was to assess smoke-free compliance in public service vehicles in Karachi.
Assessment Report on Implementation of West Pakistan Tobacco Vend Act in the Urban Areas of Islamabad
This report assesses the model and achievements of the implementation of The West Pakistan Tobacco Vend Act-1958 since 2015.
Stakeholder Mapping Tool
This online tool was developed by WHO to support stakeholder mapping in Family Planning but can be adapted for use in tobacco control.
Tobacco Atlas 6th edition and Companion Website
The sixth edition of Tobacco atlas and its companion website provide comprehensive guidance on tobacco control issues and tools used to counter them. Use the Tobacco Atlas to explore key issues and solutions and the companion website to search for country specific information.
Smoke-Free Baguio Resources and Reporting Site
City of Baguio, Philippines, smokefree website shares good practices from the city, provides a platform for reporting smokefree policy violations and contains a database of protocols and forms for enforcement actions.
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, QUITTING TOBACCO USE, 2019
This report, WHO’s seventh in the series, provides a country-level examination of the global tobacco epidemic and identifies countries that have applied selected measures for reducing tobacco use. This report focuses on supporting tobacco users to increase cessation success.
GLOBAL TOBACCO INDUSTRY INTERFERENCE INDEX, 2020
This report uses publicly available information on tobacco industry interference in 34 countries and their respective governments’ responses to these interferences to interpret key findings and rank the countries on several interference indicators.
Tobacco Control Laws
Search and download factsheets and summaries of tobacco control legislation and regulations from around the world. Search by country, region, keyword, tobacco control measure, or type of legal action.
WHO Key Elements of Tobacco Control Legislation
The World Health Organizations Tobacco Free Initiative (TFI) list of key elements of legislation for tobacco control.
Case Study: Regulatory approaches to tobacco products, menthol in tobacco products
This set of case study, focusing specifically on regulations of menthol in tobacco products, provide practical guidance to countries by describing effective regulatory strategies in tobacco product regulation, including lessons learned and challenges encountered in developing and implementing menthol related regulation.
WHO Tobacco Product Regulation: Basic Handbook
The “Tobacco product regulation: basic handbook” provides a basic reference document for non-scientist regulators in any country and serves as a tool for health authorities and other interested parties seeking resources and planning on how to monitor, evaluate, and regulate tobacco products. Further, the handbook includes relevant country case studies detailing specific approaches enacted globally.
WHO Tobacco product regulation: building laboratory testing capacity
The new tobacco laboratory guide is a useful resource for countries, and provides regulators and policymakers with comprehensible information on how to test tobacco products, what products to test, and how to use testing data in a meaningful way to support regulation.
Measures to Control the Tobacco Supply Chain
A review of fiscal markings, track-and-trace mechanisms, and licensing systems in the ASEAN region.
CounterTobacco.Org Resource Centre for Point-of-Sale
This site is dedicated to countering tobacco at the point-of-sale and offers evidence-based descriptions of the problem, policy solutions, advocacy materials and news updates.
License to Kill?: Tobacco Retailer Licensing as an Effective Enforcement Tool
This report looks at retailer licensing to support enforcement, and for controlling the location and concentration of tobacco retailers and imposing additional restrictions on the sale and promotion of tobacco products.
Evaluating the impact and equity of a tobacco-free pharmacy law on retailer density in New York City neighbourhoods
This study models the reduction in tobacco retailer density following the ban to examine differences in the policy’s impact across neighbourhoods.
Tobacco retail licensing systems in Europe
This paper aims to stimulate a discussion on the potential for tobacco retail licencing in Europe and examines the cases of Finland, Hungary, France, Italy and Spain.
WHO Compliance Data for smokefree and TAPS
Country-level compliance data that accompanies the WHO's annual report on the Global Tobacco Epidemic.
Global progress in tobacco control: the question of policy compliance
This study aims to describe and compare global trends in legislation and compliance of smokefree and TAPS policies between 2009 and 2019.
Implementation of tobacco control law by police personnel in India
Implementation of tobacco control law by police personnel in India. This study aimed to assess knowledge and attitudes.
Media Beacon Tobacco Control Campaigns
Media Beacon is an online resource from Vital Strategies of tested and proven, best practice media campaign materials designed to support tobacco control health objectives.
Global Tobacco Control: Learning from the Experts online course
This course offers free instructional training to people interested in learning more about tobacco control.
Global Health Advocacy Incubator
The Global Health Advocacy Incubator by Campaign for Tobacco-Free Kids provides strategic support to advocates planning and executing high impact campaigns to enact and implement laws that save lives.
Dhuann Smokefree Ad Campaign
Smokefree ad from India depicting the dangers of secondhand smoke and sharing information on the smoking ban in public places. Adaptions from Turkey and Bangladesh and the press release materials from each ad.
Webinar Tobacco Industry Tactics: Barriers to Effective Implementation and Enforcement
The Union is partnered with experts to highlight real world case studies on how the tobacco industry undermines tobacco control policy implementation and enforcement, with a focus on the retail environment. View the webinar presentations and learn about the strategies adopted to limit the impact of these tactics on the implementation of tobacco control policies.
Compliance with smoke-free policies at indoor and outdoor public places: an observational study in Pakistan
Study investigating smoke-free compliance across public places in Karachi, the most populous city in Pakistan.
Tobacco Control Enforcement Policy: Australia, 2022
This policy outlines the principles used to guide the Australian Government's decisions and actions in enforcing tobacco advertising, packaging and product laws.
Article 5.3 implementation in Uganda and the challenge of whole-of-government accountability
This analysis focuses on understanding difficulties in managing industry engagement across government ministries and in developing effective whole-of government accountability for tobacco control.
Reducing Tobacco Retail Density in San Francisco: A Case Study
This case study describes the San Francisco Tobacco Retail Density Policy, examines the key strategies and lessons learned in developing a retail density policy, and explores the early impact of the policy in the first year of implementation.
Measures to Control the Tobacco Supply Chain
A review of fiscal markings, track-and-trace mechanisms, and licensing systems in the ASEAN region.
Tobacco retailer density and tobacco retailers near schools in two cities of East India, Ranchi and Siliguri
This study assesses the number and density of tobacco vendors in the cities of Ranchi (Jharkhand) and Siliguri (West Bengal), and the number of retailers selling tobacco near schools. Both of these jurisdictions have passed local tobacco vendor licensing laws.
SEATCA Smoke-Free Index
A report detailing Implementation of Article 8 in the ASEAN region, 2020.
Decriminalizing Commercial Tobacco: Addressing Systemic Racism in the Enforcement of Commercial Tobacco Control
A joint statement from a consortium of US public health organizations setting forth principles to help health departments, decisionmakers, advocates, and other stakeholders advance equitable enforcement practices related to the purchase, possession, sale, and distribution of all tobacco products.
Advanced country practices in the implementation of WHO FCTC Article 13 and its guidelines
Advanced practices and lessons learned from Parties in the implementation of Article 13, with a focus on combatting cross-border advertising and the depiction of tobacco in entertainment media.
Best practices on implementation of the tobacco advertising and display ban at point of sale (Article 13 of the WHO FCTC): a four-country case study
This report reviews the relevant legislation related to the POS advertising and display bans and examines experience with enforcement and monitoring in four countries: Ireland, Norway, Finland and the UK.
WHO report on the global tobacco epidemic 2021: addressing new and emerging products
The eighth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 including data on electronic nicotine delivery systems, such as ‘e-cigarettes’.
Point-of-Sale Tobacco Advertising and Promotions, and Tobacco Product Display in Ranchi City, India
From November-December 2020, this study examined the compliance of tobacco vendors with the tobacco advertising, promotion and sponsorship (TAPS) law, and the presence of tobacco product display and warning signage at the POS in Ranchi.
Tobacco Vendor Density and Tobacco Vendor Proximity to Educational Institutions in Ranchi City, India
This study conducted a census of all tobacco vendors across three wards in Ranchi between November 2019 and January 2020, assessing the density of these vendors and their proximity to educational institutions.
Point-of-Sale Tobacco Advertising and Promotions, and Tobacco Product Display in Siliguri, India
From November-December 2020, this study examined the compliance of tobacco vendors with the tobacco advertising, promotion and sponsorship (TAPS) law, and the presence of tobacco product display and warning signage at the POS in Siliguri.
Tobacco Vendor Density and Tobacco Vendor Proximity to Educational Institutions in Siliguri, India
This study conducted a census of all tobacco vendors across five wards in Siliguri between November 2019 and January 2020, assessing the density of these vendors and their proximity to educational institutions.
Evaluation of Tobacco Free Film and Television Policy in India
This study was conducted to gauge the extent of implementation of the tobacco free film rule in India, to identify patterns in compliance and violations, and to identify opportunities for strengthening the rule.
Examples of Tobacco Control Law Educational Ads in Bangladesh
Two examples of educational campaign ads that ran in Bangladesh to inform the public of existing laws prohibiting smoking in public places, tobacco advertisements, promotion and sponsorship (TAPS) and sale of tobacco to and by minors.
Examples of Smokefree Tobacco Control Campaigns in Vietnam
Three examples of education campaigns in Vietnam focusing on the health harms of smoking around others in public places and restaurants, smoking tobacco in the workplace, and the penalties applicable for people who smoke on public transport.
National Tobacco Control Strategies Toolkit
A toolkit to provide a roadmap for establishing multisectoral strategies, plans and programmes for tobacco control in line with WHO FCTC Article 5.1.
Webinar - Public monitoring and reporting violations
The Union partnered with experts to highlight real world case studies on using innovative technology to support public monitoring of tobacco control laws. View the webinar presentations to learn about best practices and how these tools can improve implementation.
Tobacco Control Implementation and Enforcement Factsheet
The Union’s Tobacco Control Department produced a new factsheet on Implementation and Enforcement and offers a deep dive into the topic, summarizing evidence, defining key terms, and providing practical guidance and evidence-based recommendations.
Case Study - São Paulo Breathes Better: Adoption of Smoke-Free Indoor Environments
This two part case study presents the initial implementation process of tobacco-free environments in São Paulo, Brazil after The São Paulo Anti Tobacco Law was passed in 2009, and it's continued implementation 10 years later. Documents available in Portuguese.
Webinar - Enforcement Best Practices for Effective Implementation of Tobacco Control Laws
The Union partnered with experts to highlight experiences using best practices for effective enforcement and implementation of tobacco control laws. View the webinar presentations to hear lessons learned from real-world case studies.
北京控烟社会共治
2015年6月,《北京市控制吸烟条例》正式实施。次年,北京市控烟协会推出“VIP”控烟模式,即志愿者(Volunteer)+互联网(Internet )+新闻宣传(Press)模式。“VIP”控烟模式为北京市控烟协会摘得世界卫生组织授予的“西太平洋地区世界无烟日奖”,并被世界卫生组织推广到全球多个国家和城市。
EXAMPLES OF TAPS BAN PROTOCOLS
Examples of tobacco advertisement, promotion and sponsorship (TAPS) ban protocols to support the implementation of various TAPS ban policies.
Smokefree implementation in Colombia: Monitoring, outside funding, and business support
Assessment of the national smokfree policy implementation in Colombia.
WEBINAR - Harnessing the power of data for effective implementation of tobacco control laws
The Union partnered with a panel of experts to hear about their experiences collecting and using data to improve the implementation of tobacco control laws. Watch this webinar to learn about types of data that can support implementation, including tools and best practices in data collection and to hear about real-world examples of harnessing the power of data to improve policy implementation, common challenges and tips on how to overcome them.
WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Convention on Tobacco Control.
Global Tobacco Control Progress Hub
The Global Tobacco Control Progress Hub is a fully interactive data visualization platform brings together multiple datasets for easy navigation, interpretation, and analysis, and can be used to assess global progress in tobacco control.
Webinar - BUILDING TOBACCO-SMOKE FREE CITIES: LESSONS LEARNED FROM THE UNION’S IMPLEMENTATION PROGRAM
Watch this webinar to hear cities share their experiences implementing smokefree laws, bans on tobacco advertising, promotion and sponsorship (TAPS) at points-of-sale and tobacco vendor licensing policies. Hear real world examples of building a tobacco-smokefree city, their successes, challenges and lessons learned. Ask the speakers questions to learn more and identify strategies to accelerate progress in improving compliance through your future implementation efforts.
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic
Letter to the editors of the IJTLD which assesses the impact of lockdown (shelter-in-place orders) on TB case notifications.
How to manage children if a second wave of COVID-19 occurs
A letter to the editors of the IJTLD arguing that we should avoid restrictions on children’s lives during any new waves of COVID-19 – and avoid school closures.
Adapting TB services during the COVID-19 pandemic in Mumbai, India
A letter to the Editors of the IJTLD on adaptations to TB services that could help ensure continuity of services for RR/MDR-TB during COVID-19.
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria
Letter to the editors giving an early view into the impact of COVID-19 on TB diagnosis in Nigeria, a high burden setting for TB.
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease
A letter to the editors of the IJTLD which highlights the need to mitigate the risk of researchers being exposed to TB and other airborne pathogens.
COVID-19 and TB control in immigrant communities
Letter to the editors highlighting the disparity of impact of COVID-19 and TB on immigrant communities and the need to have affordable healthcare.
How TB and COVID-19 compare: an opportunity to integrate both control programmes
Letter to the editors which highlights similarities and differences between TB and COVID-19 – and proposes that control programmes unite to address both conditions.
COVID-19: ensuring continuity of TB services in the private sector
Pakistan has the fifth largest global burden of TB, and in response to COVID-19 a lockdown was imposed on 26 February. TB services were severely disrupted. This threatened to undermine recent gains in private-sector engagement and TB elimination efforts.
Responding to COVID-19: adjusting TB services in a low-burden setting
A letter to the editors in which the Victorian Tuberculosis Program describes how the social and programmatic changes to TB services brought on by COVID-19 have been experienced in practice.
COVID-19 in Africa: community and digital technologies for tuberculosis management
This letter explores the concerns about the negative impact that COVID-19 will have on the fight against tuberculosis in Africa
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic
This letter looks at the implications and potential consequences of delayed or missed diagnoses for TB, which may increase TB-related hospitalisations and death.
COVID-19 and tuberculosis—threats and opportunities
In an editorial to the IJTLD, the authors state how we must overcome the challenges that COVID-19 presents and use the opportunities it affords us to achieve a paradigm shift in TB treatment and care
Severe COVID-19 cases with a history of active or latent tuberculosis
In a letter to the editors, authors report on symptom development, disease progression and treatment for three cases, each representing a different TB scenario.
Common concerns in managing bronchial asthma during the COVID-19 pandemic
A letter to the editors of the IJTLD addresses the major concern of use of corticosteroids and nebulised bronchodilators in bronchial asthma during the COVID-19 pandemic
Rapid development of a portable negative pressure procedural tent
A new tent system has been designed to provide healthcare workers separation and protection from exhaled droplets and aerosols, while allowing contact and support for procedures.
Rapid development of a novel portable negative pressure device
A portable, negative pressure environment is one means of confronting these challenges, and could offer benefits to patients, healthcare workers, and institutions alike.
COVID-19 in Africa: preparing for the storm
In response to COVD-19, Africa should develop robust collaborative research programmes, funded by African governments and partners, to include epidemiological, health system, implementation, clinical trials, immunological and virological research.
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed
Letter highlighting that responsible stewardship of the bacille Calmette-Guérin (BCG) vaccine in the context of the COVID-19 epidemic is urgently needed.
Impact of COVID-19 on tuberculosis services in India
Letter to the editors of the IJTLD addresses the impact of COVID-19 on tuberculosis services in India, and the need to ensure the availability of key equipment to care for patients and to ensure the safety of health care workers.
Impact of COVID-19 on patients with asthma
Letter to the editors of IJTLD exploring the outcomes of patients with asthma in Northern Italy, exploring whether SARS-CoV-2 affected their asthma.
Resource reprioritisation amid competing health risks for TB and COVID-19
Letter to the editors of the IJTLD that highlights health care responses to COVID-19 that might help TB care in the longer term.
Professor Sir Alimuddin Zumla wins the prestigious 2020 Mahathir Science Award
The Union is delighted to share the news that Professor Sir Alimuddin Zumla, Union Medal winner, supporter and friend of The Union, has been awarded the prestigious 2020 Mahathir Science Award.
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China
Letter to the editors of the IJTLD describing a significant decline in TB detection during the COVID-19 pandemic in Shanghai – highlighting the need for improved programmes to minimise the impact of any future lockdown on the control of TB.
The Union starts a Wave Money platform to support people with MDR-TB during the COVID-19 pandemic
In Myanmar, The Union has set up a ‘Wave Money’ platform to transfer financial support to people via mobile phone or through local agents, helping people unable to use automated teller machines.
Impact of COVID-19 on TB diagnosis in Northeastern Brazil
In the context of the global pandemic, there is an urgent need for research that elucidates the relationship between COVID-19 and TB, the adoption of strategies that protect TB patients from infection by SARS-CoV-2, and the adoption and/or strengthening of strategies to ensure the diagnosis of TB during the pandemic period.
Prestigious scholarship for TB activist Nandita Venkatesan
The TB survivor, journalist and activist from Mumbai, India, has been awarded the scholarship to Oxford University.
Union World Conference announces new VIP speakers
UNAIDS Deputy Executive Director, Shannon Hader, and Katherine Maher, CEO of the Wikimedia Foundation, and Her Royal Highness Princess Dina Mired of Jordan will speak at the conference.
How lessons from COVID-19 could impact TB and mental health
The COVID-19 pandemic has taught us to think outside the box and change the way services are delivered to meet patient needs. These may just become the new “best practices”.
Union World Conference announces VIP speakers and publishes scientific programme
Her Royal Highness Princess Dina Mired of Jordan, Katherine Maher, CEO of the Wikimedia Foundation, UNAIDS Deputy Executive Director Shannon Hader and Dr Anthony Fauci, Director of NIAID will all speak at the 51st Union World Conference on Lung Health, held virtually from 20-24 October.
President Bill Clinton and WHO Director-General Dr Tedros Adhanom Ghebreyesus to speak at the Union World Conference
They will address the opening ceremony of the 51st Union World Conference on Lung Health, taking place virtually 20-24 October 2020. TB survivors Tamaryn Green and Divya Sojan will also speak of the impact of the COVID-19 pandemic on those affected by TB in their respective countries.
Union statement on the 2020 WHO Global TB Report
The latest Global Tuberculosis Report has been launched by the World Health Organization. José Luis Castro, Executive Director of The Union responds.
Global luminaries open the Union World Conference on Lung Health, marking The Union’s centennial
As The Union celebrates its one hundredth birthday, we embark upon the first-ever virtual Union World Conference, in an Opening Ceremony unprecedented for its line-up of international luminaries. Including President Bill Clinton and WHO Director-General Dr Tedros.
The Union World Conference gathers global leaders for innovative science against the backdrop of COVID-19
Marked by global luminaries and held during the official centennial of The Union, the 51st Union World Conference on Lung Health provided an opportunity to celebrate a hundred years of leadership in lung health.
Scientific highlights from the Union World Conference
Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, led a special session on the development of a vaccine for SARS-CoV2.
Message from the Executive Director
Concluding 19 years of service to The Union
Bedaquiline: Rolling out the first new TB drug since 1960
A special thematic issue of The Union's International Journal of Tuberculosis and Lung Disease explores increasing access to this vital treatment for multidrug-resistant TB.
The Union’s Director of TB, Dr Grania Brigden makes intervention at Rome 5
The Union’s Director of TB, Dr Grania Brigden makes intervention at Rome 5
The Union urges for progress to end the preventable burden of pneumonia
On World Pneumonia Day, The Union, with partner the Forum of International Respiratory Societies, calls for governments and health care providers to take decisive action in the fight again pneumonia.
Urgent call for continuity of TB services during the COVID-19 pandemic in China
Our survey revealed that COVID-19 led to a significant disruption in TB diagnosis and care at major hospitals throughout China. We urgently call for additional investment directed toward improving the availability of diagnostics and therapeutics such that equitable access to care can be maintained during times of crisis.
TB and COVID-19 co-infection: rationale and aims of a global study
The potential impact of COVID-19 on TB patients and services continues to generate significant attention. Although several concerns have been raised, scientific evidence remains modest.
New report shows critical delays delivering the latest standards of tuberculosis care
The report from Stop TB Partnership and Médecins Sans Frontières shows critical delays in updating national policies in 37 high burden countries to reflect the latest international guidance in key areas of TB care.
Union Guide is blueprint for national TB guidelines around the world
Seventh edition of The Union’s popular technical guide ‘Management of Tuberculosis: A Guide to Essential Practice’ now available in French and Spanish.
Union Achiever
“TB is the underdog of infectious diseases and I have always wanted to fight for the underdog”
The latest TB R&D developments must pave the way for greater investment
Last week saw critical announcements on tuberculosis research and development, which show important progress in the field. The Union calls for greater knowledge and data sharing to ensure that scientific research can have the biggest impact in the fight to end TB.
Statement on TB in migrants during the COVID-19 pandemic
The Union’s TB and Migration working group has released a statement stressing that there must not be neglect of TB among migrants during the COVID-19 pandemic.
Indonesia: Leveraging COVID compliance to catalyse tobacco control
Spearheaded by The Union, two Indonesian cities are simultaneously tackling the COVID-19 virus and tobacco control violations by embedding smokefree monitoring into sanitation inspections.
Groundbreaking paper documents history of tobacco promotion in Indian television and cinema
Union experts co-author an important new study “Tobacco imagery in entertainment media: evolution of tobacco-free movies and television programmes rules in India.”
Tobacco use and quitting behaviour during COVID-19 lockdown
A survey has revealed that nearly two thirds of tobacco users reported an intention to quit smoking during lockdown in Chennai, India.
5th APCAT Summit unites leaders on NCDs and tobacco during COVID-19
The 5th APCAT Asia Pacific Summit of Mayors brought leaders together to share their insights and exchange experiences of the COVID-19 crisis, particularly in relation to tobacco control and NCD prevention.
Flying during the COVID-19 pandemic
Science-based guidance on reducing the risks of flying during the pandemic, from Union experts.
Announcing the 52nd Union World Conference on Lung Health
The Union World Conference will take place from 19-22 October. Wherever you are in the world, join us to know, share and act to find solutions to the biggest issues in lung health for this new era.
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
The authors highlight the use of community testing as a means of addressing the impact of COVID-19 on TB diagnosis.
Union launches new tobacco control implementation resource
The Tobacco Control Implementation Hub is a one-stop shop for tobacco control policy implementation and enforcement resources.
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
The authors investigate the potential impact of COVID-19 on people with RR-TB.
Impact of influenza A co-infection with COVID-19
This study reports on the rate of co-infection with influenza A in a cohort of COVID-19 patients and its impact on the clinical course and outcome.
Tackling TB and COVID-19: US leadership is needed on global health, now more than ever
In the lead up to World TB Day, an article in PHA calls for increased funding and renewed leadership to coordinate the global fight against TB. A relatively small investment in TB control has the potential to transform TB care, saving millions of lives and trillions of dollars in the global economy.
The impact of COVID-19 on TB: a review of the data
In this recently accepted Review for IJTLD, the authors summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts.
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
In this recently accepted article for IJTLD, the authors performed a cohort-comparison study to assess Pretomanid in a regimen to treat drug-resistant TB: patients receiving the BPaL regimen had a significantly better 6-month post-treatment outcome than those on the B–L regimen. The preprint is free to read.
Asymptomatic COVID-19 – implications for the control of transmission in South Africa
The authors conducted a retrospective analysis to determine the proportion of asymptomatic COVID-19 in the workplace during lockdown in early 2020. Nearly 45% of cases were asymptomatic, which has implications for interventions, such as enforcing quarantine of all close contacts of COVID-19 cases regardless of symptoms.
New Union technical publication: 1st edition - Basic occupational safety and health for respiratory diseases: a desk guide for health facilities
This desk guide outlines a comprehensive approach to respiratory health, which health facilities can adapt and implement in resource-limited settings. Its development was supported by a review committee consisting of Union members with interest and expertise in this subject matter.
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
In this recently accepted article for IJTLD, the authors found that RR-TB diagnosis decreased by 21–38% following the start of the pandemic. The results are disturbing and suggest that COVID-19 has had a sustained impact at a time when household transmission of TB/RR-TB might have increased due to ‘shelter at home’. The preprint is free to read.
Impact of COVID-19 on TB detection in the private sector in Nepal
In this Correspondence accepted article for IJTLD, the authors found a 67.4% decrease in testing, a 66.9% decrease in bacteriologically confirmed (bac+) diagnosis and a 58.9% decrease in diagnosis of all forms TB. The preprint is free to read.
Call to action for an invigorated drive to scale up TB prevention
An Editorial for IJTLD highlights the importance of TB preventive treatment (TPT) and the launch by WHO, governments, civil society and other partners of a ‘Call to Action’ for broader access to TPT for those in need. The article is free to read.
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19
On 18th July 2021, we celebrate the 100th anniversary of the first use of the BCG vaccine for TB. An Editorial in IJTLD discusses BCG’s efficacy, heterologous protection and controversial link with COVID-19. The preprint is free to read.
BCG and The Union a 100-year history
On 18 July 1921, a newborn baby received a dose of an experimental vaccine called Bacille Calmette-Guérin (BCG). Fast forward 100 years and it is the most widely used vaccine globally – billions of children have been vaccinated and countless children’s lives have been saved worldwide.
Thrombotic events and COVID-19 vaccines
In this State of the Art, the authors reviewed the literature on thromboembolic adverse events reported after vaccination for COVID-19, and review the benefits and risks of the vaccines approved for use. The preprint is free to read.
Will heated tobacco products be banned in Hong Kong?
The Bill to ban heated tobacco products in Hong Kong has been delayed, causing the authors to write to the IJTLD highlighting the risks of introducing new tobacco products. The preprint is free to read.
Surgical antibiotic prophylaxis administration practices
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Antibiotic resistance in patients with chronic ear discharge awaiting surgery in Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
High antibiotic resistance and mortality with Acinetobacter species in a tertiary hospital, Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Antimicrobial resistance in neonates with suspected sepsis
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Pseudomonas aeruginosa in Nepali hospitals: poor outcomes amid 10 years of increasing antimicrobial resistance
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Low yield but high levels of multidrug resistance in urinary tract infections in a tertiary hospital, Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
COVID Response to save lives in Myanmar
In Myanmar, The Union established the COVID-19 Response Programme in 29 Union project sites to prevent the severity of disease, mitigate negative impacts of COVID-19 and to save lives.
A bold new future for the IJTLD
The IJTLD is changing for a bold new future. Read about how we are adapting the Journal in an Editorial for the October issue. The preprint is free to read.
Incidence of healthcare-associated infections with invasive devices and surgical procedures in Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Annual consumption of parenteral antibiotics in a tertiary hospital of Nepal, 2017–2019: a cross-sectional study
One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.
Down syndrome and COVID-19, a combination with a poor prognosis
The authors of this Letter assess the impact of COVID-19 on a series of patients with Down syndrome. The preprint is free to read.
Memorable and successful virtual #UnionConf
The 52nd Union World Conference on Lung Health took place virtually from 19-22 October and it was an engaging and eye-opening virtual event.
It was four days filled with pathbreaking science, some of which got extensive media coverage – including Ryan Dinkele’s research which made it to The New York Times, Tuberculosis, Like Covid, Spreads in Aerosols, Scientists Report as well as results of the Practecal trial led by Médecins Sans Frontières which got covered in The Telegraph New hope for patients as ‘gruelling’ treatment for drug resistant TB could be cut to six months and the promising fingerstick blood test that was featured in Devex Fingerstick blood test can be a promising TB screening tool, study finds. These articles were only the tip of the iceberg, we received tremendous media coverage this year.
We would like to extend a special thank you to all our delegates who attended the Union World Conference – your participation was invaluable and contributed immensely to the success of the event. As a registered delegate, you can view the session recordings on the virtual platform till December 31, 2021.
We look forward to welcoming you again next year.
Lifetime burden of disease due to incident tuberculosis
New study finds the consequences of post-tuberculosis adds substantially to the disease burden caused by tuberculosis. The Centre for Operational Research at The Union was part of the global research collaboration.
Reflections on the ‘Other COP’ – Progress on Tobacco Control Despite COVID and Industry Attacks
Gan Quan, The Union's Director of Tobacco Control, looks back at COP9 for Health Policy Watch.
Opportunities to prevent and manage undernutrition to amplify efforts to end TB
High rates of undernutrition are a key driver of the TB epidemic. In this mini review (to be published in the January issue of IJTLD) the authors highlight the need to do more to address undernutrition and its importance for public health. The preprint is free to read.
Evaluation of screening international travellers for COVID-19
The authors have monitored post-arrival screening for COVID-19 to evaluate its effectiveness. The preprint is free to read.
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi
COVID-19 and poor air quality is leading to increased use of mechanical ventilation, but the authors of this article question how effective these systems are in important buildings in India. The preprint is free to read.
An exciting new future for Public Health Action
An overview of the new Editorial plan for Public Health Action
The IJTLD on World TB Day
A selection of articles from IJTLD to mark World TB Day 2022.
The war in Ukraine and potential consequences for the TB epidemic in Europe
Correspondence in a forthcoming issue of IJTLD examines the impact of the war in Ukraine on healthcare systems in the area, including both Eastern and non-Eastern European countries and future management of TBI and TB disease. The preprint is free to read.
The Asthma Drug Facility and the future management of asthma
An Editorial in the next issue of the IJTLD examines lessons learned from the Asthma Drug Facility and how this informs future plans for asthma management. The preprint is free to read.
WHO drug-resistant TB guidelines 2022: what is new?
An Editorial in a forthcoming issue of the IJTLD examines the WHO's recent rapid communication on key changes to the treatment of drug-resistant TB. The preprint is free to read.
Progress on indoor air quality regulation in India
The power of the pen - Correspondence in a forthcoming issue of the IJTLD highlights how a Letter to the Editor helped to progress legislation on indoor air quality in India. The preprint is free to read.
Treatment of Multidrug-Resistant Tuberculosis: The latest guidance from WHO
Treatment of multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult. Dr Chen-Yuan Chiang, Senior Consultant at The Union, discusses the World Health Organization's latest rapid communication.
The impact of COVID-19 on TB control for vulnerable groups
Z. Aranda and H. J. Sánchez-Pérez call on health providers, researchers and decision-makers to develop studies and interventions that address the impact of COVID-19 on TB control in vulnerable populations.
The IJTLD: the story continues
An Editorial in the IJTLD explains the increase in the Journal's impact factor and describes how we are improving the Journal for authors and readers. The preprint is free to read.
PHILIPPINES RESTORES THE FDA AND DOH’S AUTHORITY TO REGULATE TOBACCO PRODUCTS
After a 11-year battle, the Philippines’ Supreme Court ruled to uphold the authority of the Food and Drug Administration (FDA) and the Department of Health (DOH) to regulate all products affecting health, including tobacco products. This reverses a 2011 petition filed by the Philippine Tobacco Institute—its members include Philip Morris Philippines Manufacturing, Inc., Fortune Tobacco Corp., La Suerte Cigar, and Cigarette Factory—to prevent tobacco products regulation by the FDA and DOH.
The importance of localised programmes and tailored training to tackle TB infection
Dr. Nacho Monedero shares his views on importance of localised programmes, why governments need to continue investing and his experiences travelling the world to further our mission to end TB.
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022
A Letter in a forthcoming issue of the IJTLD highlights the impact of the war in Ukraine on TB services. The preprint is free to read.
The war in Ukraine is an environmental catastrophe
An Editorial in a forthcoming issue of the IJTLD highlights the impact of the war in Ukraine on environmental pollution. The preprint is free to read.
Combating the tridemic: new guidelines, masking and altruism
An Editorial in a forthcoming issue of the IJTLD highlights the impact of the tridemic of COVID-19, influenza and respiratory syncytial virus. The preprint is free to read.
New Year, New Knowledge
Monthly ‘round-up’ news item – January 2023
Working together to meet your training needs
Monthly ‘round-up’ news item – February 2023
Myths, misconceptions, and half-truths about TB
The Union shares facts about tuberculosis (TB) to dispel 13 myths, misconceptions, and half-truths getting in the way of ending TB.
New Community Advisory Panel elected
The Union has elected a new Community Advisory Panel (UCAP). UCAP consists of engaged members of affected communities and civil society from across the world.
Meet the new UCAP members.
GPT-4, artificial intelligence and implications for publishing
An Editorial in a forthcoming issue of the IJTLD highlights the implications of artificial intelligence for publishing. The preprint is free to read.
Nepal's Prime Minister commits to end TB and tobacco
In March, Dr Tara Singh Bam, Director of The Union Asia Pacific met with the Prime Minister of Nepal to discuss strategies to prevent non-communicable diseases, tuberculosis (TB) and tobacco use.
Analysis of the Indian Government’s position on the use of asbestos and its health effects
An article in a forthcoming issue of PHA highlights the Indian Governments attitude to asbestos – and the health implications of this. The preprint is free to read.
Specialized training in clinical and programmatic management of DR-TB in Eritrea
Monthly ‘round-up’ news item – March 2023
Enhancing Tuberculosis Care and Prevention: Join our Internationally Acclaimed Training Courses!
Monthly ‘round-up’ news item – May 2023
Mise à jour thérapeutique et pronostique de la rupture utérine dans une maternité à Bangui, CAR
An article in a forthcoming issue of PHA describes the prevalence, associated factors and fatality due to uterine rupture. The preprint is free to read.
Contribution des diagnostics au points de service dans l’identification de la maladie à VIH avancée
An article in a forthcoming issue of PHA assesses point-of-care (POC) diagnostics for the early detection of advanced HIV disease (AHD), and in its presence, TB and cryptococcosis, in Democratic Republic of the Congo (DRC)
Reference des cas de traumatisme par arme à feu en Afrique
An article in a forthcoming issue of PHA assesses the factors influencing the unfavourable outcome of cases referred for firearm trauma in a war-torn African country.
Risk of TB nine times higher in prisons globally
For the first time ever researchers, sponsored by The Union, have estimated the rate of tuberculosis (TB) in incarcerated persons, having analysed data from almost every country in the world (193 out of 195 countries) between 2000 and 2019.
Assessing TB-related comorbidities, risks and disability in China
A new study in China has found that it was possible and valuable to assess people with tuberculosis (TB) for symptoms, comorbidities, risk factors and disability at the start and end of TB treatment.
Experts identify clinical standards for adverse effects to TB treatment
A panel of 65 global experts have identified eight clinical standards for the management of adverse effects during treatment for tuberculosis (TB).
Community perspective on child-friendly medications for drug-resistant TB: importance, priorities and advocacy
An Editorial in a forthcoming issue of the IJTLD highlights the need for child-friendly medications for drug-resistant TB. The preprint is free to read.
The latest training and education at your fingertips
Monthly ‘round-up’ news item – June 2023
Milestone 30th Edition of The Union's International Tuberculosis Training Advances Fight Against TB with Hybrid Learning in Cotonou
Recently, The Union launched the 30th edition of its hugely successful international tuberculosis training course – sharing the latest insights and best practices in the global fight against TB.
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress
An Editorial in a forthcoming issue of the IJTLD highlights the need for access to medications for drugs for TB in Europe. The preprint is free to read.
The second United Nations high-level meeting on the fight to end TB: action is needed to turn the tide by 2030
An Editorial in the September issue of PHA highlights the need to accelerate progress towards TB elimination.
The Union supporting TB-free villages in India
Villages across India are being supported to become tuberculosis-free, as part of a wider self-sufficiency drive. The Union, through the iDEFEAT TB Project and Corporate TB Pledge, is providing technical assistance to implement the programme in 115 villages.
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
The Union launches new open access journal
IJTLD Open is a new open access journal to improve and broaden access to scientific knowledge. It officially launches on 1st January 2024 with a call for papers.
Hugh Blackbourn, Director of Publications at The Union, said: “A key part of the Union’s mission is the effective dissemination of knowledge, so we are delighted to launch a new OA journal with no barriers to access.
International Course on the Clinical Management of DRTB
Latest updates on the management of DRTB
Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
An Editorial in a forthcoming issue of IJTLD Open highlights the need for further progress in tackling TB in children and adolescents. The preprint is free to read.
“RUNNING OUT OF EXCUSES”: TB LEADER CONDEMNS INACTION IN ERADICATING TB AS UNION WORLD CONFERENCE BEGINS
The Union World Conference on Lung Health 2023 - Wednesday 15 November opening press release
NEW GLOBAL RESEARCH: FOUR NEW, IMPROVED DRUG REGIMENS COULD CUT TREATMENT TIME FOR DRUG RESISTANT TUBERCULOSIS BY UP TO TWO-THIRDS
The Union World Conference on Lung Health 2023 - Wednesday 15 November press release
NEW RESEARCH: SAFER, SHORTER, AND MORE EFFECTIVE TREATMENT DISCOVERED FOR TB
The Union World Conference on Lung Health 2023 - Thursday 16 November press release
‘THE TIME FOR THE GLOBAL TB COMMUNITY TO ACT IS NOW’ - NEW RESEARCH SHOWS FAILURE OF CURRENT POLICIES TO ERADICATE TB
The Union World Conference on Lung Health 2023 - Friday 17 November press release
Open access and the future of the IJTLD
An Editorial in a forthcoming issue of IJTLD describes the rationale for launching IJTLD OPEN. The preprint is free to read.
NEW RESEARCH: HOW DRONES ARE TACKLING TB IN THE HIMALAYAS
The Union World Conference on Lung Health 2023 - Saturday 18 November press release
“7-1-7” timeliness metric is valuable to TB household contacts
New research led by The Union finds the “7-1-7” timeliness metric to be valuable for screening and supporting household contacts of people with tuberculosis.
The Union's Centre for Operational Research is assessing the use of the metric in India, Kenya and Pakistan.
A reflection on 2023
Prof Guy Marks, President and Interim Executive Director, reflections on the dedication, hard work and achievements of The Union in 2023.
Using timeliness metrics for household contact tracing and TB preventive therapy in the private sector, India
A forthcoming article in an issue of IJTLD describes the use of a timeliness metric for effective screening of household contacts. The preprint is free to read.
Nutritional acquired immunodeficiency (N-AIDS) a key driver of TB Pandemic
One in five incident TB cases were attributable to malnutrition, more than double the number attributed to HIV/AIDS. Like HIV/AIDS, malnutrition is a cause of secondary immunodeficiency, known as nutritionally acquired immunodeficiency syndrome (N-AIDS). The Union and research partners have reviewed decades of data and made the case that N-AIDS deserves special consideration in the effort to eliminate TB.
IJTLD OPEN has launched
The Union has launched the first issue of IJTLD OPEN – a fully-compliant, open access journal to enhance our coverage of tuberculosis (TB) and lung disease.
This first issue of IJTLD OPEN features Editorials (highlighting TB in children and adolescents; and the need for action after the UN High-Level Meeting on TB) and a mix of Original Articles on TPT initiation; screening of household contacts for TB infection; Omicron SARS-COV-2 infection’; timeliness metrics for screening and preventing TB; and priorities for EMR countries to achieve TB elimination.
Watch a video on the launch of IJTLD OPEN https://youtu.be/nXW7wHSG1DM
Analysis of mesothelioma cases and National Cancer Registry data to assess asbestos exposure in India
An article in a forthcoming issue of PHA assesses the number of cases of mesothelioma to highlight the dangers of asbestos use in India.
Hundreds benefit from free online course to help diagnose Child Tuberculosis
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
The Union’s training courses can help improve your TB knowledge
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
Barriers to TB preventive treatment remain in Uganda, despite improvements
New research shows barriers to accessing tuberculosis (TB) preventive treatment remain in Uganda, even though coverage is high amongst many people living with HIV.
TB among refugees from Ukraine in European countries
Ahead of World TB Day, an article in a forthcoming issue of IJTLD OPEN assesses TB rates in refugees from Ukraine.
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, an article in a forthcoming issue of IJTLD OPEN assesses patients successfully completing TB treatment for comorbidities, risk determinants and disability in health facilities in Kenya, Uganda, Zambia and Zimbabwe.
The Union to launch a course to empower researchers in low or middle income countries
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
Mises à jour du Kit de Formation Gratuite : Tuberculose chez l'Enfant et l'Adolescent - Guide pour les Agents de Santé
Kit de formation gratuit sur la tuberculose chez les enfants et les adolescents
The Union launches Principles of TB Care and Prevention course
The Union launches Principles of TB Care and Prevention course
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea
An article in a forthcoming issue of PHA assesses the reasons for loss-to-follow-up in patients being treated for disease resistant TB.
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
Seventeen countries have benefited from The Union’s international courses
Free Online Course on CXR Interpretation for Child Tuberculosis Diagnosis
A year in review – evaluating the launch of IJTLD OPEN
An Editorial in a forthcoming issue of IJTLD OPEN describes how open access has driven a dramatic increase in visibility.
Pilot ‘Training of Trainers’ TB programme delivered in Lesotho
Over 40 healthcare professionals attended pilot training programme organised by The Union to strengthen TB management and control in sub-Saharan Africa.
This training, developed and organised by The Union in collaboration with the Global TB Branch (GTB) of the U.S. Centers for Disease Control and Prevention (CDC), aimed to enhance Child and Adolescent TB management skills among healthcare providers.
The Union appoints infectious disease expert as new Executive Director
The Union has announced its appointment of a new Executive Director, Dr Cassandra Kelly-Cirino.
With over two decades’ experience in improving health outcomes in low- and middle-income countries, Dr Kelly-Cirino has worked extensively with vulnerable populations disproportionately affected by communicable and non-communicable diseases.
The Union delivers first blended learning international TB course in English
The Union has delivered its first blended learning international course on Principles of TB Care and Prevention: Translating Knowledge to Action since 2018.
The Union response to WHO Global TB report 2024
Dr Cassandra Kelly-Cirino, Executive Director, The Union: “While it’s heartening to see some positive trends in our battle against TB, we must confront a harsh reality: despite our efforts, we are merely treading water, failing to make significant strides toward our goal of ending TB."
Empowering Healthcare Professionals to Combat Drug-Resistant Tuberculosis
The Union has delivered its first blended learning international course on Principles of TB Care and Prevention: Translating Knowledge to Action since 2018.
Income-related disparity in country TB rates
A new analysis of global tuberculosis (TB) data reveals that lower income countries are disproportionately affected by TB.
The Union found that low-income, lower-middle income, and upper-middle income countries consistently reported higher TB rates from 1995 to 2022, compared to high-income countries.
A reflection on 2024
From changing WHO guidelines and identifying key improvements to drug-resistant TB management, to being awarded grants from the Global Fund in Myanmar and the Gates Foundation for an active case finding project in India to delivering another fantastic Union Conference.
After such an impressive year for The Union, Dr Cassandra Kelly-Cirino and Prof Guy Marks look back at everything we have accomplished in 2024.
In conversation with Cassandra
We grabbed five minutes with Dr Cassandra Kelly-Cirino to learn more about her motivation for becoming our new Executive Director, vision for the future and the unique role of The Union.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
Basic page node field test title
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
landing page tall tile
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
News tile 1 CEO and Moving Together to Build a Healthier World
Effective and accessible health systems, with people - centred care offered through a primary healthcare model, are vital to serve families and communities affected by TB.
News tile 3 World Lung Day
In a week marked by global protests and the United Nations Climate Action Summit, the welfare of the entire planet is at forefront of the political agenda about heal.
Join our vision and help the union today
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque id eros ac lectus semper mattis eget commodo nibh. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Union world wide conference
Pellentesque id eros ac lectus semper mattis eget commodo nibh. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Image tile 1 test
Pellentesque id eros ac lectus semper mattis eget commodo nibh. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Tile Style test 2 yellow
Pellentesque id eros ac lectus semper mattis eget commodo nibh. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Project Axshya
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
DETECT Child TB project
In Uganda, the DETECT Child TB project empowered frontline health workers to provide TB screening to 2270 child TB contacts, meaning diagnosis happened in village health centres, rather than central hospitals, catching the disease earlier and lessening burden on hospitals.
Child & Adolescent Tuberculosis
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
Online submissions
text
The IJTLD
The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.
We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
Public Health Action
Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.
We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable Development Goals (SDGs).
Bloomberg Initiative to Reduce Tobacco Use Grants Program
The Union has managed 495 Bloomberg tobacco control grants in 45 countries.
TREAT TB
Read more about TREAT TB (Technology, Research, Education and Technical Assistance for Tuberculosis), an ambitious initiative that was launched by The Union, seeking to contribute new knowledge regarding shorter, more tolerable treatment regimens for MDR-TB.
Integrated HIV Care Programme - Myanmar
Through its Integrated HIV Care (IHC) Programme, The Union Office in Myanmar currently provides services to nearly 34,000 People Living with HIV, more than 33,400 of which are taking antiretroviral treatment.
Tobacco advertising
subtitle: The tobacco industry spends billions of dollars on advertising to increase sales
The Union has helped 4.13 billion people in 28 countries through advertising bans.
TB-HIV, TB-Diabetes and other co-morbidities
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Union Office in India
C-6, Qutub Institutional Area
110016 New Delhi
India
Phone: (+91) 11 46 054 400
Phone: (+91) 11 46 054 430 / 429
The Union Office in Myanmar
Ma-10/41-42, 64th St, between 101st & 102nd St
Chan Mya Thar Zi
Mandalay
Myanmar
Phone: (+95) 9 409973377, (+95)9 944973377
Tobacco control
The Union has helped:
• 3.82 billion people in 37 countries through smoke-free laws
• 3.87 billion people in 28 countries through higher tobacco tax
• 4.11 billion people in 33 countries through graphic health warnings
The Union Headquarters in Paris
2 Rue Jean Lantier
75001 Paris
France

The Union Switzerland Office
Chemin Valmont 224
1260 Nyon
Switzerland
The Union Uganda Office
Plot 2, Lourdel Road
Nakasero Hill Kampala
P.O. Box 16094 Wandegeya, Uganda
Phone: (+256) 414 341 604
Fax: (+256) 414 341 598
Research
Each year, The Union Centre for Operational Research trains over 1,000 participants from around the world, resulting in more than 1,500 papers being published.
Conferences
The Union has been organising conferences around the world on lung health and related issues for over a hundred years.
The Union World Conference on Lung Health is the world’s largest gathering of clinicians and public health workers, health programme managers, policymakers, researchers and advocates working to end the suffering caused by lung disease.
Union Conferences
In 2019 and early 2020, The Union convened six international conferences in India, South Africa, Panama, Philippines, the United States of America and Canada, all with the overarching aims of sharing knowledge and best practice.
Union Courses
The Union's Training and Education Department organises online and face-to-face. In 2023, over 4,500 people were trained globally.
Technical Assistance
Our goal is to provide assistance that addresses both national priorities and international standards, policies and objectives.
The Union’s focus is on working hand-in-hand, in partnership with the country.
The Global Asthma Network
In collaboration with the International Study of Asthma and Allergies in Childhood, The Union founded the Global Asthma Network (GAN) which published The Global Asthma Report 2018, an 88 page cutting edge State-of-the-Art report, with contributions from 53 experts around the globe.
Global TB Caucus
The Union is a founding partner of the Global TB Caucus, an international network of more than 2,500 Members of Parliament in over 150 countries, dedicated to ending TB through strengthening health systems. To date, members have launched 53 National TB Caucuses over the world.
Careers
L’Union a obtenu un financement de l’Agence Française de Développement pour la mise en œuvre du projet CETA. Pour la mise en œuvre de ce projet il est prévu des visites régulières dans les pays impliqués dans le projet CETA ainsi que la participation à différentes réunions internationales. C’est dans ce cadre que le présent appel d’offre international est lancé afin de contractualiser avec une agence de voyage pour l’organisation de ces différentes missions.
Course on the Clinical Management of Drug-Resistant Tuberculosis 2021
18 November to 9 December 2021 (3 weeks)
Online. Course in English.
Find out more
L’Union lance la 7ème édition du Cours International sur la Tuberculose Multirésistante 2025
6 au 10 Octobre 2025
Cours présentiel. Cours en français.
En savoir plus
Fast-Track Journal Articles
The Union is fast-tracking the publication of certain accepted articles from the International Journal of Tuberculosis and Lung Disease.
Technical publications
Technical guides on TB, tobacco control, lung health and more, written by experts.
Achieving high compliance rates through enforcement and implementation
Hear from tobacco control implementation experts who share their experiences of achieving high compliance with tobacco control laws, through real-world case studies.
List of Tracks
Sessions and abstracts must be submitted under one of the official tracks for the conference
Post-graduate Courses & Workshops
Widen your knowledge with a range of interesting courses and workshops. First course takes place on September 28.
Information for Speakers
All you need to know if you are a speaker or presenter (oral abstract, symposium or e-poster)
Session submission guidelines
Submission guidelines for satellite sessions, symposia, post-graduate courses and workshops
Community Connect 2021
Inspire, engage and give a voice to the community (Submissions are closed; View Community Connect Schedule here)
TBScience 2021
Basic and translational TB research
(Submissions are closed; View TBScience Programme here)
Late-Breaker Sessions
New, significant and innovative findings in TB, COVID19, Lung Health (Submissions closed; Notifications on acceptance/non acceptance sent)
Registration
Registration for the 52nd Union World Conference on Lung Health is now open
The Role of Strategic Communication and Mass Media for Tobacco Control Policy Implementation
Hear from tobacco control implementation experts who share their experiences of achieving high compliance with tobacco control laws, through real-world case studies.
PHA preprints
The Union is fast-tracking the publication of certain accepted articles from PHA.
Cours International sur la Lutte contre la Tuberculose 2025
Avril 2025
Cours format hybride - en ligne avec visite terrain. Cours en français.
En savoir plus
Child and Adolescent TB for Healthcare Workers
The Union, in collaboration with the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), has updated material that supports teaching and learning on tuberculosis in children and adolescents.
A DR-TB Academy for all healthcare workers
The Union has developed a DR-TB Academy to train physicians, nurses and other health workers on detection, diagnosis and treatment of Drug Resistant TB.
Tobacco Industry Tactics: Barriers to Effective Implementation and Enforcement
Hear from tobacco control implementation experts who share their experiences of achieving high compliance with tobacco control laws, through real-world case studies.
Course on the Clinical Management of Drug-Resistant Tuberculosis 2022
13 October to 3 November 2022 (3 weeks)
Online. Course in English.
Find out more
Course on the Clinical Management of Drug-Resistant Tuberculosis October 2022
13 October to 3 November 2022 (3 weeks)
Online. Course in English.
Find out more
Enforcement Best Practices for Effective Implementation of Tobacco Control Laws
Hear from tobacco control implementation experts who share their experiences of achieving high compliance with tobacco control laws, through real-world case studies.
IJTLD Open
Launched in January 2024, IJTLD Open is The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD.
We welcome submissions on the development of diagnostics and treatments for the prevention, management and control of respiratory diseases.
Using Data to Improve Public Health Outcomes
Based upon our Principles of Management in Tuberculosis Care and Prevention, The Union developed TBData4Action, a training program on TB data specific to the needs of the Government of Kenya.
SORT IT (Structured Operational Research Training IniTiative) Courses
The SORT IT training teaches the practical skills to conduct and publish research and foster evidence-informed decision making.
Explore The Union Courses Catalogue 2025-2026
Save the dates!
Find out more
Principles of Tuberculosis Care and Prevention: Translating Knowledge to Action 2025
New dates: August to October 2025
Hybrid course - online and field visit. Course in English.
To learn more
NEW - International Course on Tuberculosis in Children and Adolescents 2025
New dates: June to August 2025
Hybrid course - online and field visit. Course in English.
To learn more
International Course on the Clinical and Programmatic Management of Drug-Resistant Tuberculosis 2025
13-17 October 2025
In-person. Course in English.
Prof Guy Marks
Prof Guy Marks is an Honorary Professor of Medicine, University of New South Wales (Australia). An expert on asthma and airway disease, he leads a TB research programme with Viet Nam's National TB Programme. He has been active in The Union since 1993.
President: The Union President is responsible for carrying out the decisions of the Board and ensuring the correct functioning of the organisation.

Prof Guy Marks
President
Guy Marks is a respiratory and public health physician and epidemiologist. He is President of the International Union Against Tuberculosis and Lung Disease.
Guy is Senior Principal Research Fellow at Burnet Institute in Australia. He also serves on the Board of the NCD Alliance and the Federation of International Respiratory Societies (FIRS). He is a former member of the steering committee of the Global Asthma Network. He led the Centre for Air pollution, energy and health Research (CAR, an NHMRC Centre of Research Excellence) from 2012 to 2022.
He is an Adjunct Professor at UNSW Sydney and an Honorary Professor at University of Sydney. His main research interests are in chronic respiratory disease (asthma and COPD), tuberculosis and protection from airborne hazards (both infectious and non-infectious).

Dr Robert Horsburgh
Dr Horsburgh is Professor of Epidemiology, Biostatistics, Global Health and Medicine at Boston University. He is an experienced TB clinician whose research has focused on TB epidemiology, clinical trials and community engagement in TB elimination.
He was President of the Union North American Region from 2019 to 2021 and Vice President of The Union from 2019 to 2023.
He is currently Co-Chair of The Union’s DR-TB Working Group and Chair of the Steering Committee of RESIST-TB, an international organisation that advocates for global expansion of improved treatment for Drug-resistant TB.

Dr Paul Nunn
(United Kingdom), Secretary General
Following 20 years in the WHO, Stop TB Department, Paul Nunn is currently a consultant working mainly on policy and strategy development in tuberculosis in low-income countries, based in London, UK. He worked on several projects with The Union during his time at WHO, and was elected Chair of the TB Section in 2017, joining the Board at the same time.
Secretary General: The Secretary General supervises the implementation of decisions taken and is responsible for Board meetings, minutes, correspondence and the register.

Richard Shepro
Richard Warren Shepro is an international lawyer and law professor who teaches at the University of Chicago and is Senior Counsel at the law firm Mayer Brown LLP.
After joining The Union’s Board in 2014 he was a Bureau member and Treasurer from 2017-2023.
He holds degrees from Harvard College, The London School of Economics and Harvard Law School and is a former editor of the Harvard Law Review. Having advised boards of directors for more than 40 years, he is the author of a prominent textbook and has published in Harvard Business Review, the Financial Times, and the Review of Financial Economics.
He is also an expert in the history and law of gastronomy, subjects he has lectured and published about widely. Professor Shepro is trustee of the Oxford Symposium on Food & Cookery and a director of Lyric Opera of Chicago, Alliance Française de Chicago, and other organisations.

Dr Jeremiah Chakaya Muhwa
(Kenya), Past-president
Dr Chakaya has been a leader in TB control throughout his career, in his home country of Kenya and on the global stage. Until recently the Chief Research Officer for the Kenya Medical Research Institute, he has led the National TB Control Programme as its head from 2003 to 2006 and continues to act as a technical expert for the National Programme.

Mr Arinze Austin Obiefuna
(Ghana), Africa Region

Dr Ral Antic
(Australia), Asia Pacific Region

Prof Zohar Mor
(Israel), Europe Region
Dr Paula Lasserra
(Uruguay), Latin America Region
Prof Mohamed Awad Tag Eldin
(Egypt), Middle East Region

Dr Robert Horsburgh
(USA), North America Region

Mr Chaudhary Muhammad Nawaz
(Pakistan), South-East Asia Region

Kevin Schwartzman
(Canada), Tuberculosis Section

Dr Amy Bloom
(United States of America), HIV Scientific Section

Dr Andrew Steenhoff
(United States of America), Adult & Child Lung Health Section

Omara Dogar
(UK), Tobacco Control

Prof Xiaolin Wei
(Canada)

Dr Paul Nunn
(United Kingdom)

Dr Erlina Burhan
Dr Erlina Burhan is a distinguished pulmonologist and lung infection specialist at the Persagabatan General Hospital - Faculty of Medicine, University of Indonesia.
Focused on clinical work in TB diagnosis and management, she specialises in both drug-sensitive and drug-resistant TB at Indonesia's national referral hospital for respiratory diseases.
Actively involved in TB research, Erlina contributes to numerous scientific publications nationally and internationally. She is a member of the WHO guideline development group and collaborates with the American Thoracic Society on international standard guidelines for TB care. Erlina also represents the Private Sector Providers Constituency in the Stop TB Partnership.

Dr Mira B Aghi
(India)

Dr Kosuke Okada
(Japan)

Dr Pamela Orr
(Canada)

Ingrid Schoeman
(South Africa), Secretary General
Ingrid Schoeman was working as a dietitian in a public hospital when she became sick with XDR (Extensively Drug-Resistant) TB. She was hospitalised for 75 days of which one month was spent in ICU as she developed liver failure from the TB medication. TB changed her life. “I’m glad this happened to me, now I can relate to the suffering of so many people of South Africa.” Today she is a TB advocate part of TB Proof, passionate about person-centred high quality TB care for all.
Secretary General: The Secretary General supervises the implementation of decisions taken and is responsible for Board meetings, minutes, correspondence and the register.

Dr Keren Middelkoop
Vice President
Dr Keren Middelkoop is an experienced clinician working in one of the highest TB and HIV burdened countries in the world. She has worked as a clinical researcher and epidemiologist in this field for nearly 20 years. Her work has spanned a wide range of studies including observational and epidemiological studies and clinical trials.
Keren's early work included exploring the interaction of HIV and TB epidemics at a population level and the impact of HIV antiretroviral therapy on TB rates in communities with high burdens of both diseases. More recent work includes transmission of TB – infection prevalence studies, molecular epidemiology studies and proof of concept studies exploring methods for detecting airborne Mtb in congregate settings.
Most recently she has served as Principal Investigator on clinical trials assessing biomedical interventions for TB prevention – both infection and disease.

Luan Vo Nguyen Quang
Treasurer
Luan is President of Friends for International TB Relief. Luan has supported the Vietnam National TB Control Program in the implementation and evidence generation for active case finding, private sector engagement, social protection and TB prevention.
He contributed to the National Action Plan to End TB, led the 2015-2020 End-term Program Review and is a member of the Global Fund Country Coordinating Mechanism’s technical advisory group on TB. Luan is also a consultant for the Stop TB Partnership.
Luan has a master of public health from the London School of Hygiene and Tropical Medicine. Prior to public health, Luan worked in financial advisory and pharmaceutical consulting.

Prof Guy Marks
subtitle: President
Prof Guy Marks is a respiratory and public health physician and epidemiologist. He is President and interim Executive Director of the International Union Against Tuberculosis and Lung Disease. He also serves on the Board of the NCD Alliance.
He has led the Centre for Air pollution, energy and health Research (CAR, an NHMRC Centre of Research Excellence) since 2012. His main research interests are in chronic respiratory disease (asthma and COPD), tuberculosis control and the adverse health effects of exposure to air pollution.
In 2022, Guy was recognised in the Queen’s Birthday Honours List, as an Officer in the General Division of the Order of Australia, for distinguished service to respiratory medicine and research, and to tertiary education.

Prabodh Bhambal
subtitle: Deputy Executive Director, and Chief Financial Officer
Prabodh Bhambal, MBA, brings over 20 years of budget, finance and project management experience to his work at The Union. Prior to joining us, he was a financial consultant for WHO and Programme Officer for the Aga Khan Foundation.
Deputy Executive Director: oversees global operations and financial management and deputises for the Executive Director as needed.
Chief Financial Officer: overall management responsibility for The Union’s finances, focusing on strengthening the organisation’s current position, as well as further developing its financial management, control and capabilities.

Dr Paula I Fujiwara
subtitle: Scientific Director
Paula I Fujiwara, MD MPH, was seconded by the US Centers for Disease Control (CDC) to The Union in 2001. She served as Director of the Departments of HIV and TB, before becoming Scientific Director in June 2013.
Scientific Director: supervises The Union’s technical departments, providing guidance and oversight on all projects and activities.

Dr Jamhoih (Jamie) Tonsing
subtitle: Deputy Scientific Director and Director of The Union South-East Asia Office
Dr Jamhoih (Jamie) Tonsing has over 15 years of clinical and public health experience, providing technical assistance to Ministries of Health and implementing complex multi-stakeholder projects in her home country of India and across South-East Asia, before joining The Union in 2014.
Deputy Scientific Director and Director of The Union South-East Asia Office: defines scientific priorities with a focus on the Asia region, and provides leadership and management of the programme activities of The Union South-East office and oversight of the development, funding and implementation of the strategy in the region.

Paul Jensen
subtitle: Director of Policy and Strategy
Paul Jensen joined The Union in 2014. He has extensive experience advocating for stronger health policies and financing and providing strategic services to international organisations.
Director of Policy and Strategy: analyses health policy issues for both internal audiences and external stakeholders, including governments and the media.

Marianne Gaye-Ayrault
subtitle: Global Training and Education Director - Managed Units
Marianne Gaye-Ayrault has over 15 years of experience in higher education, business development and marketing, as well as strategic consulting and fundraising. Ms. Gaye-Ayrault holds an MBA from Georgetown University, McDonough School of Business in Washington, DC and a B.A. in Business Administration from the MBA Institute, part of the Groupe INSEEC in Paris, France.

Nathalie Emaille-Léotard
subtitle: Global Director of Human Resources - Central Services
Nathalie Emaille-Léotard, MBA, MIM, became Global Director of Human Resources in 2013 after more than 15 years as an international consultant, helping companies align their business and human resources strategies.

Jove Oliver
subtitle: Senior Advisor – Communications
Jove Oliver became Senior Advisor, Communications in 2016, bringing 15 years of experience in designing and implementing results-driven media, communications and digital strategies to address global health challenges.
Senior Advisor, Communications: plans, develops and implements external and internal communications, branding and public relations activities.

Prof Anthony Harries
subtitle: Senior Advisor, Research
Prof Anthony D Harries spent over 20 years in sub-Saharan Africa, working on TB, HIV/AIDS and TB-HIV. Author of hundreds of published papers, in 2008, he joined The Union to launch the Department of Research.

Dr Gan Quan
subtitle: Director, Tobacco Control Department
Dr Gan Quan completed his PhD in Public Health and a post-doc on tobacco control research. Since 2009, he has managed China’s Bloomberg Initiative tobacco control grants, developed campaigns and conducted policy research. He became Director of The Union China Office in 2014 and Director of the Tobacco Control Department in 2017.

Gustavo Sóñora
subtitle: Regional Director of Latin America
Gustavo has been working for The Union since 2008. He has been a long-time champion for tobacco control in the region and a well-respected tobacco control expert particularly in issues related to Framework Convention on Tobacco Control and interference from the tobacco industry. A native from Uruguay, Gustavo has played a key role in helping the Uruguayan government in passing some of the most progressive policies in tobacco control and winning the landmark legal case against Philip Morris.
Regional Director of Latin America: overall leadership, development, coordination, implementation and promotion of The Union’s tobacco control activities in the Latin America Region.

Professor Kevin Mortimer
subtitle: Director, Lung Health - Scientific Departments
Professor Kevin Mortimer went to medical school at the University of Cambridge and did a PhD at the University of Nottingham. He moved to the Liverpool School of Tropical Medicine in 2011 as Senior Clinical Lecturer and Honorary Consultant in Respiratory Medicine at Aintree University Hospital NHS Foundation Trust. He is co-Deputy Director of the NIHR Global Health Research Unit on Lung Health and Tuberculosis in Africa at LSTM and was co-Principal Investigator in the Cooking and Pneumonia Study.

David Jackson
subtitle: Director, Conferences
David Jackson has an extensive background in international events management and communications for the third sector and non-profit bodies, including environmental, agricultural and arts organisations. He brings to The Union a wealth of experience and a collaborative leadership style that has ensured the successful creation and management of a broad range of live flagship events.
Cathy Ditchfield
subtitle: Director of Membership - Managed Units
Cathy has over 15 years of experience in membership, marketing and communications. Having recently been Director of Membership for the Royal Institute of British Architects and UK Youth, she has a successful track record of cultivating communities and engagement programmes to enable member organisations to flourish. Cathy has rich experience of modernising and redeveloping membership offers and structures to fit evolving financial landscapes and to support organisational growth.

Hugh Blackbourn
subtitle: Director, Publications
With more than 20 years of experience in publishing, Hugh has a strong track record in assisting publishers to improve the performance of their journals, including their scientific impact, financial performance, author services and sponsorship opportunities. He has worked as the Publisher for Nature Journals and Nature Reviews Journals; the Head of Publishing for the Wellcome Trust; and advised a range of publishers (including Oxford University Press, Company of Biologists and the British Medical Journal) on a broad array of online and print initiatives.
Meaghan Derynck
subtitle: Global Director of Communications
Meaghan brings to The Union an extensive background in communications ranging from media production, PR and film production. She has managed communications and advocacy for a range of NGOs, including leading the strategic communications for civil society around the United Nations High-level Meeting on TB.
Global Director of Communications: leads a global team delivering marketing, branding, PR, social media, multimedia content and events for all elements of The Union’s work, and advises on all elements of communications to ensure The Union speaks with one, strong voice.

Dr Riitta Dlodlo
subtitle: Senior Advisor
Dr Riitta Dlodlo, MD, MPH, has worked in both clinical and programmatic TB, TB-HIV and management of health services and projects for over 30 years in Zimbabwe and other sub-Saharan African countries. Having joined The Union in 2003, she has served as TB-HIV programme coordinator and Director of the Department of TB and HIV from 2015 to mid-2019, when she was appointed Senior Advisor.

Dr Grania Brigden
subtitle: Director, Department of Tuberculosis - Scientific Departments
Before working with The Union, Grania was TB and AMR Advisor for the Médicins Sans Frontières Access Campaign to develop and implement the core priorities of the TB Dossier. Prior to MSF, Grania worked in Uganda with Voluntary Services Overseas at the International Hospital Kampala and Reach Out Mbuya, a non-governmental organisation, and in Banda Ache, Indonesia with Medic Global Sikhs/Waves of Mercy.

Dr Ajay Kumar
subtitle: Director, Department of Research
Dr Ajay Kumar is a seasoned Public Health Practitioner with over 15 years of experience in low- and middle-income settings. He has worked for WHO-India as a consultant for providing technical assistance to the Government of India’s National Tuberculosis Programme, particularly in leading TB-HIV co-ordination activities. He is an author/co-author of over 170 publications, with many contributing to a change in policy/practice and has facilitated over 75 national and international courses.

Professor Kevin Mortimer
subtitle: Director, Lung Health
Professor Kevin Mortimer went to medical school at the University of Cambridge and did a PhD at the University of Nottingham. He moved to the Liverpool School of Tropical Medicine in 2011 as Senior Clinical Lecturer and Honorary Consultant in Respiratory Medicine at Aintree University Hospital NHS Foundation Trust. He is co-Deputy Director of the NIHR Global Health Research Unit on Lung Health and Tuberculosis in Africa at LSTM and was co-Principal Investigator in the Cooking and Pneumonia Study.

Prabodh Bhambal
subtitle: Director, The Union Asia Pacific Office and Interim Director, The Union South East Asia Office
Prabodh Bhambal brings over 20 years of experience in budget, finance and project management to this new position. He also serves as The Union's Deputy Executive Director and CFO.
The Union Asia Pacific Office is the International Union Against Tuberculosis and Lung Disease Asia Pacific Ltd., a registered charity in Singapore and Union organisational member. Strong on tobacco control, it is expanding to include TB, road safety and other issues.
The Union South-East Asia Office, established in 2003, was The Union’s first region office. Today it coordinates Project Axshya's massive TB outreach effort; manages tobacco control grants and conducts operational research, training and other activities.

Dr Jamhoih (Jamie) Tonsing
subtitle: Director, The Union South-East Asia Office
Dr Jamhoih (Jamie) Tonsing trained as a psychiatrist but soon changed her focus to TB. She worked on projects across South-East Asia for WHO and Family Health International before moving back to her native India as Director of The Union South-East Asia Office in 2014.
The Union South-East Asia Office (USEA), established in 2003, was The Union’s first region office. Today USEA coordinates Project Axshya's massive TB outreach effort; manages tobacco control grants and conducts operational research, training and other activities.

Nick Southern
subtitle: Director, The Union Office in Myanmar
Nick Southern brings 30 years of experience in global development to his work in Myanmar. He has previously worked on issues from sustainable programme development and policy formulation to disaster response and community engagement. Most recently, he was Southern Africa Regional Director for Save the Children International.
The Union Office in Myanmar is a registered international non-governmental organisation in Myanmar since 2012. Located in Mandalay, it provides TB, HIV and TB-HIV services with the Ministry of Health, Department of Public Health and other partners.

John Paul Dongo
subtitle: Director, The Union Uganda Office
John Paul Dongo has worked with The Union since 2011, most recently he supported The Union's DETECT Child TB Project which showed that strengthening child TB services in Uganda was associated with increased case finding and improved treatment outcomes. He is also The Union's lead for the Sub-Saharan Africa Regional Child and Adolescent TB Centre of Excellence.
1st Prize
1st prize
2nd Prize
3rd Prize
1st Prize
2nd Prize
3rd Prize

1st Prize

2nd Prize

3rd Prize
2nd Prize
3rd Prize

1st Prize

2nd Prize
1st Prize
2nd Prize
3rd Prize
TREAT TB
subtitle: More information about TREAT TB is available at treattb.org
More information about TREAT TB is available at treattb.org

THE UNION UK OFFICE
61 Dublin Street
Edinburgh
EH3 6NL
United Kingdom

Our impact: Research
In 2019, The Union conducted research in 41 countries and developed 162 research studies. Nine operational research fellows worked in Africa and Asia.

Research tile
In 2019, The Union conducted research in 41 countries and developed 162 research studies. Nine operational research fellows worked in Africa and Asia.

TITI Study
In Benin, The Union’s TITI Study enrolled 2000 children at increased risk of getting TB over an 18-month period. Ninety percent of the children enrolled were started on preventative therapy and five percent were diagnosed with active TB and placed on treatment.

DETECT Child TB
In Uganda, the DETECT Child TB project empowered frontline health workers to provide TB screening to 2270 child TB contacts, meaning diagnosis happened in village health centres, rather than central hospitals, catching the disease earlier and lessening burden on hospitals.
Maintaining essential child and adolescent TB services during the COVID-19 pandemic: practical solutions and lessons learnt
subtitle: Thursday 3 September, 13:00 - 14:30 PM CEST
Although the primary risk of coronavirus infection in young people with co-morbidities such as TB, HIV, or severe malnutrition is still uncertain, the negative impact of the pandemic on this already vulnerable population is becoming clear.
Programmatic Management of TB in High Burden Countries During Initial COVID-19 Response
subtitle: Thursday 30 April, 12.00-13.00 CEST
Chairs: Dr Grania Bridgen, The Union and Dr Francesca Conradie, Helen Joseph Hospital
Speakers: Dr Dennis Falzon, WHO, Dr Vivian Cox, and Dr Norbert Ndjeka, National TB Programme of South Africa
COVID-19 and Tuberculosis: Finding Synergies to Advance the Fight.
subtitle: Thursday 7 May, 12.00-13.00 CEST
Speakers: Dr KS Sachdeva (TBC), Indian NTP, Dr Masoud Dara, WHO Regional Office for Europe, and Dr Eliud Wandwalo, The Global Fund, Switzerland.
APCAT Webinar: Government accountability in responding to COVID-19, NCDs and Tobacco Use
subtitle: Tuesday 12 May, 10.00-11:30 CEST
Moderator: Shobha Shukla, Citizen News Service & Coordinator - APCAT Media
Speakers: Khagraj Adhikari, Member of Parliament, Nepal and Chair-APCAT Parliamentarians; Shameem Haider Patwary, Member of Parliament, Bangladesh; Bima Arya Sugiarto, Mayor, Bogor City Indonesia; Han Kosal, Deputy Governor, Kampong Cham, Cambodia; Jose Martinho Dos Santos Soares, Mayor Ermera City, Timor-Leste; Vinayad Prasad, World Health Organisation; Tara Singh Bam, Deputy Regional Director, The Union Asia Pacific.
Respiratory protection against TB and infectious diseases (including COVID – 19) transmitted by airborne and droplet spread
subtitle: Tuesday 12 May, 15.00-16.00 CEST
Chairs: Amanda Christensen, Australian Respiratory Council and Niesje Jansen, KNCV Tuberculosis Foundation
Speakers: Dr Carrie Tudor, International Council of Nurses, Dr Grigory Volchenkov, Vladimir Regional Tuberculosis Control Center, End TB Transmission Initiative (ETTi)
COVID-19 et prise en charge de la tuberculose en Afrique Francophone
subtitle: mercredi 20 mai, 14.00-15.00 CEST
French-language webinar
Modérateurs : Kobto Ghislain Koura et Bertrand Kampoer
Topic 1. COVID-19 : Considérations pour la prise en charge de la tuberculose. Présentateur : Dennis Falzon
Topic 2. Comment la communauté peut aider les PNT dans le contexte du COVID-19. Présentateur : Edouard Kambou Sansan
Topic 3. COVID-19 : Expérience du PNT du Bénin. Présentateur : Wachinou Prudence
Panel discussion: How to prevent 1.4 million deaths: Advancing TB care and prevention in the time of COVID-19
subtitle: Wednesday 20 May, 16.00-17:00 CEST
Moderator: Victoria MacDonald, Channel 4 news
Panellists: Lucica Ditiu, Stop TB Partnership, Marijke Wijnroks, The Global Fund, Tereza Kasaeva, WHO, Cheri Vincent, USAID, Catharina Boehme, FIND, José Luis Castro, The Union, Subrat Mohanty, The Union
Desafíos para enfrentar la interferencia de la Industria Tabacalera en tiempos del COVID-19
subtitle: jueves 28 de mayo, 10:00-11:00 CDT
Spanish language webinar:
Moderadores: Gustavo Sóñora y Cristiane Vianna
Participación especial: Dra Vera Luiza da Costa e Silva
Expositores: Silvana Rubano Turci, Jorge Vega Cárdenas, Rodrigo Bolaños
Monitoring the COVID-19 Pandemic in sub-Saharan Africa: paying attention to health facility admissions and deaths
subtitle: Wednesday 10 June, 14:00-15:00 CEST
Speakers: Former Union President Jeremiah Chakaya, Leo Martinez, Anthony D Harries.
COVID-19 and TB: Personal perspectives
subtitle: Thursday 18 June, 14:00 - 15:00 CEST
Kate O’Brien and Ezio Tavora Dos Santos Filho, both TB survivors, will chair the discussion. The panellists will be: Claire Forlani, film and television actor and Union Ambassador. Dr Purna C. Kashyap, a COVID-19 survivor, based in the USA. Ms Athira Elssa Johnson, who is currently receiving treatment for TB, and living in Kerala, India. Dr Thato Mosidi, XDR TB survivor, who lives in South Africa.
Fumar en tiempos de COVID-19
subtitle: Mié., 24 de Jun. de 2020 16:00 - 17:45 CEST
Spanish language webinar
Los facilitadores serán el Dr. Gustavo Zabert y el Lic. Gustavo Sóñora.
Los expositores serán la Dra. Laura Llambí, el Dr. Rogelio Pérez Padilla y el Dr. Carlos Jiménez Ruiz. Con comentario especial del Dr Eduardo Bianco.
TB preventive therapy: recent advances and future prospects
subtitle: Tuesday 23 June, 16:00 - 17:00 CEST
TB remains the number one global infectious-disease killer and prevention remains key to its elimination. While prevention of any infectious disease makes intuitive public health sense, TB prevention has been a relatively neglected area in TB control efforts until recently.
A luta contra a dupla carga de TB e COVID-19 no Brasil
subtitle: Qua, 01 Jul 2020 às 16:00 - 17:00 CEST
Portuguese language webinar
Facilitadores: Anete Trajman (Universidade do Estado do Rio de Janeiro) e Anna Cristina Carvalho (Fiocruz, MS). Apresentadores: Dr Denise Arakaki, Ministério da Saúde, Prof Ethel Leonor Maciel, Universidade Federal do Espírito Santo, Carla Almeida, CCAP-TB/Brasil.
Preserving TB and TB-HIV services in the face of an unprecedented pandemic in Africa
subtitle: Wednesday 1 July, 12:00 - 13:00 CEST
This Union member-led webinar builds on this IJTLD article, describing the TB and COVID-19 situation in Zimbabwe, and discussing safeguarding the provision of TB and collaborative TB-HIV services in Africa. Recent international guidance on TB-HIV care during COVID-19 will also be reviewed.
Where Bans Are Best: LMICs Must Prohibit E-cigarettes & HTPs to Tackle Tobacco
subtitle: Friday 10 July, 2:00 - 3:00 AM CEST
Expert speakers will discuss The Union's new position paper 'Where bans are best: Why LMICs must prohibit e-cigarettes and heated tobacco product sales to truly tackle tobacco' which considers the potential impact that novel products could have on low- and middle-income countries.
Caring for Carers - stigma awareness, attention and response
subtitle: Thursday 9 July, 14:00 - 15:00 CEST
This webinar will discuss the importance of stigma in health care facilities and amongst health care providers, and how to recognise and effectively address it. Recognising and addressing stigma in health care facilities and improving the well-being of care providers offers possibilities to create an environment free from fear and discrimination – both for the facility users as well as care providers.
COVID-19 transmission, similarities and differences with other respiratory pathogens
subtitle: Thursday, 16 July, 15:00 PM - 16:00 CEST
Speaker: Mark Jackwood, University of Georgia
Moderator: Liliana Salvador, University of Georgia, USA
Rôles et responsabilités dans la réponse au Covid-19, aux maladies non transmissibles (MNT) et au tabac
subtitle: Tuesday, 28 July, 13:00 – 15:00 CEST
French language webinar
Desafios no enfrentamento da TB-COVID-19: situação em Moçambique, manifestações clínicas em adultos e diagnóstico sorológico
subtitle: Thursday, 13 August, 16:00 - 17:00 CEST
Portuguese language webinar
Advancing the fight against childhood pneumonia in LMICs
subtitle: Thursday, 27 August, 14:00 - 15:00 PM CEST
Speakers highlight recent literature on epidemiology, diagnosis, clinical signs, risk stratification, pulse oximetry, treatment approaches, including CPAP, clinical trials, air pollution, stakeholder perspectives and prevention efforts, as well as the latest on COVID-19 as a cause of pneumonia in children.
Novel rapid diagnostics for assessing zoonotic tuberculosis
subtitle: Tuesday 8 September, 14:00 - 15:00 PM CEST
Determining the source of a zoonotic infection is generally limited to whole-genome sequencing. In this webinar, leaders in the development of new rapid TB diagnostic tests discussed the challenges and progress, including rapidly identifying cases of ZTB.
Availability of and challenges to resistance testing for second-line drugs, including the new and repurposed TB drugs
subtitle: Thursday 24 September,
The session reported on the survey of Union members and members of Global Drug Initiative and Global Laboratory Initiative about the availability of drug susceptibility testing, followed by a discussion of potential strategies to expand this availability.

Elena Agafonova
subtitle: Union Courses Testimonial
Elena Agafonova is the head of the Arkhangelsk Regional Centre for medical prevention in Russia. Her work focuses on identifying strategies to lower the prevalence of health risks to the public.
Agfonova attended the course “Management and Leadership” specific to officials working in tobacco control. She found the course provided a strong framework for sharing experiences and learning from each other and was pleased to find instructors and participants discussing overcoming challenges much like those faced by her organisation.

Gokul Mishra
subtitle: Union Courses Testimonial
When Gokul Mishra, an experienced programme designer, project manager and trainer, became the focal person to Nepal for Norway’s LHL International Tuberculosis Foundation (LHLI) in 2010, one thing was immediately clear: he would need to build a strong network of partners to succeed in his new job.
Mishra decided to enroll in “Influencing, Networking and Partnership,” a course teaching techniques for collaborating and negotiating with diverse stakeholders. He found the mix of lectures and practical exercises such as role-playing were useful tools to grow as a manager.

Ravizah Hamid
subtitle: Union Courses Testimonial
Ravizah Hamid heads the National Tuberculosis Coordinating Centre for the Department of Health in Brunei Darussalam.
“The courses I’ve attended have given me valuable knowledge in TB control and management. The Union has developed me into a good team leader and manager and has also increased my confidence through learning.”
TB and Mental Health: An overview
subtitle: Friday 9 October, 14:00 - 15:00 PM CEST
This webinar is hosted by The Union’s TB and Mental Health working group, in partnership with Survivors Against TB, a community group that works with TB survivors and diverse stakeholders to advocate on creating patient and community focused paradigms of care in TB in India.

Dr E. Jane Carter
Dr E. Jane Carter has dedicated her career to tuberculosis. She is both an Associate Professor of Medicine at Brown University, USA, and Director of the Brown Kenya Medical Exchange Programme at Moi University, Kenya. In Rhode Island she worked with the Department of Health sponsored TB Clinic for over 22 years. She is a past president of The Union. In recognition of her global health work, she was awarded the World Lung Health Award from the American Thoracic Society in 2013. Her TB work has focused on active case finding in resource limited areas as well as improving the care cascade for paediatric care and prevention.

Dr Chen-Yuan Chiang
Dr Chen-Yuan Chiang is a clinician specialising in respiratory and critical care medicine. He is a member of the Core Group of Global Drug-Resistant TB Initiative, the TB Technical Advisory Group of WHO Western Pacific Region, the Regional GLC in the Western Pacific, and the Technical Review Panel, Global Fund to Fight AIDS, Tuberculosis and Malaria. He is Associate Professor, Department of Internal Medicine, Taipei Medical University. He is the Course Director of the international course on Clinical and Programmatic Management of DR-TB.

Dr Riitta Dlodlo
Dr Riitta Dlodlo has worked in both clinical and programmatic TB, TB-HIV and management of health services and projects for over 30 years in Zimbabwe and other sub-Saharan African countries. She joined The Union in 2003 and held various roles. Riitta coordinates the development of Union publications, leads and develops content for Union courses and provides advice in all aspects of TB. She is the course director of the Principles of TB Care and Prevention: Translating Knowledge to Action.

Dr Einar Heldal
Einar Heldal was with the national TB programme in Nicaragua, a model programme for DOTS development, from 1987 to 1990. He was the head of the TB registry in Norway from 1994-2005. Since then, Einar has been an independent TB consultant, part time with the Norwegian Institute of Public Health. He has extensive international experience in TB programme support and reviews, long-term in Russia, East Timor and Zimbabwe. Einar worked with WHO and many non-governmental organisations, especially in recording and reporting, use of routine TB data for management, operational research, MDR-TB, LTBI, ethics, migration, and prison health. He has published on TB epidemiology, TB mortality and BCG vaccination.

Dr Kobto Ghislain Koura
Dr Kobto Ghislain Koura is a medical epidemiologist. He has participated in the management of international projects and his work over these years has focused on diseases, including malaria and anaemia, in low-income countries. He also completed a post doctorate in epidemiology at Claude Bernard University in Lyon, France. Since joining The Union in 2013, his work has focused on technical assistance, operational research and education, addressing the challenges of tuberculosis in Francophone African countries. He also serves as faculty member in several courses in France and he is associated researcher to MERIT Laboratory, a laboratory of The IRD (Institut de Recherche pour le Développement), a French research organism.

Dr C. Patricia Macias
Dr C. Patricia Macias has worked for The International Union since 2014 as a faculty member for several Union TB courses. She is the Medical Director for the Tuberculosis Unit at The Cook County Department of Public Health in the Chicago area of Illinois. She is dedicated to providing care to the immigrant and disadvantaged population of the region. She is a full time Physician at the Cook County Health and Hospitals System, where she works as an Academic Pulmonary Doctor.

Dr. Alberto Mendoza
Alberto Mendoza is an Infectious Diseases and Tropical Medicine physician and master in Clinical Epidemiology and head of the TB and HIV programme and Infectious Diseases Department at Hospital Villa El Salvador, Lima, Peru. He has worked as for PAHO and The Union in Latin America on programmatic management of TB, specifically resistant and co-infection forms with HIV. He has worked with the Network of Public Health Laboratories, as coordinator of the National Reference Laboratory of Mycobacteria of the National Institute of Health, carried out clinical research as a medical researcher of AC IMPACTA (Member of the US NIH Network), and member of the Tuberculosis Transformation Group of the ACTG / DAIDS / NIH, of the United States and of the Peruvian Infectious Diseases and Pneumology Societies.

Dr Ignacio Monedero
Dr Ignacio Monedero is a medical doctor specialised in family and community medicine. He has been involved in NGO projects in developing countries, especially in tropical and infectious diseases. He has worked in more than 35 countries providing technical assistance, MDR-TB and TB-HIV trainings and supporting operational research projects. He has been involved in the writing of several Union guidelines, including TB-HIV and MDR-TB, in addition to different MDR-TB papers.

Dr Tafadzwa Priscilla Sibanda
Tafadzwa Priscilla Sibanda is a Public Health Specialist with a decade of experience in the health sector in Zimbabwe. She has worked through the various levels of health services from an intern at a tertiary hospital to positions at the district level for four years and MCH/TB/HIV programme manager at the provincial level for four years. Tafadzwa has been involved in both clinical and programme management, as well as monitoring and evaluation of these programs.

Dr Valerie Robertson
Dr Valerie Robertson is an Associate Professor in the Department of Medical Microbiology at the University of Zimbabwe. Prior to this she was to coordinator for the National Microbiology Reference Laboratory for the Zimbabwe Ministry and Health and Child Welfare. While there, she also helped to set up training for rapid HIV testing and became an investigator with the Development of Antiretroviral Therapy (DART) in Africa trial. Valerie has developed a number of trainings on bacteriology, infection control, lab safety, and rapid HIV testing and continues in an advisory role on various committees on these topics.

Dr Moorine Sekadde
Dr Moorine Penninah Sekadde is a paediatrician and public health expert with more than 15 years of experience in clinical care, capacity building, research, design and implementation of public health interventions. Her current focus area is child and adolescent TB including aspects of integration within Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCAH). She is a core team member on the WHO child and adolescent TB technical work group as well as a WHO STAG-TB member.

Dr Anita Mesic
Anita Mesic is a physician from Bosnia and Herzegovina trained in infectious diseases, public health and epidemiology. For the last ten years she has been working with Medecins Sans Frontieres as clinical and programmatic advisor to the TB, DR-TB and HIV medical projects in resource limited settings, including Myanmar, Afghanistan, Pakistan, Tajikistan, India, Democratic Republic of Congo, Zimbabwe, Nigeria and Ethiopia. Her research interest is related to adaptation of tuberculosis care in conflict affected contexts, with the special focus on shorter treatment regimens and person-centered models of care. Anita believes that the capacity building is one of the cornerstones of tuberculosis control in resource limited settings.

Dr Steve Graham
Steve Graham has served as a senior consultant in child tuberculosis and lung health for The Union since 2008. He is a paediatrician with over 20 years’ experience in clinical and operational research and training in tuberculosis and pneumonia in both the African and Asia-Pacific regions. Steve is currently based at the University of Melbourne and The Burnet Institute in Australia.

Dr Jay Achar
Dr Jay Achar is an Infectious Diseases Specialist & Epidemiologist, Karolinska Institutet, Stockholm, Sweden. Jay graduated as a medical doctor from University College London and completed his Infectious Diseases specialist training in Melbourne, Australia. He spent 7 years working for MSF as a TB/HIV/Hepatitis advisor with whom he gained clinical and programmatic experience from a wide range of countries including Uzbekistan, Tajikistan, the Russian Federation and Belarus as well as Sierra Leone, Liberia, DR Congo and South Sudan. His research interests include the treatment of DR-TB in children, the use of newer drugs to shorten treatment regimens for RR/MDR-TB and investigating the utility of aerosol sampling to stratify TB transmission risk.

Viswanath Gopalakrishnan
Viswanath “Vish” Gopalakrishnan is the Founder and Director of Organisations & Alternatives, working as a consultant in organisation development and a trainer in behavioural science. Vish’s core purpose at work is to help people realise their true potential. With a postgraduate Diploma in Management from the Indian Institute of Management, Vish is a professional member of the Indian Society for Applied Behavioural Science (ISABS) — 1996. He is MBTI Qualified by the APT Qualifying Training Program — 1998, a life member of the NHRD Network, Bangalore, and has also been on the Advisory Board of the Centre for Montessori Training in Chennai, Tamil Nadu.

Salil Kumar
Salil Kumar is a Finance and Accounting Professional with over 30 years of experience. He specialises in courses on Budget and Finance for Non-Profits. He is also associated with The India Nutrition Initiative, which has been established by the TATA Trusts to direct their investments in addressing malnutrition in India. Salil’s experience and interests go beyond finance. His aptitude and sphere of work extends much wider to include institutional growth and sustainability, programme design and implementation strategies, as well as portfolio management.

Ron Wehrens
Ron Wehrens is a pharmacist from The Netherlands. From 1993 until 1997, he lived and worked in Zambia, training pharmacy technologists at Evelyn Hone College, Lusaka. From 2000 until 2004, he joined IDA Foundation in the Netherlands. In 2004, he established Phasuma, a consultancy specialised in Pharmaceutical Supply Management for developing countries. Ron is a regular consultant for the World Health Organization, GDF and The Global Fund and has worked in Cambodia, Indonesia, Laos, Kenya, Malawi, Nepal, Oman, Pakistan, Rwanda, Tajikistan, Tanzania, Ukraine, Uganda, Vietnam, Zambia and Zimbabwe.

Dr Oriol Ramis
Dr Oriol Ramis is a Medical Doctor (Barcelona, 1979), specialised in Public Health (LSHTM, 1982) and later trained in Organisational Consultancy (Tavistock, 2001) with extensive work experience in Eastern Europe, Africa, Latin America and the Middle East. He works in strengthening health systems and in the control of tuberculosis. He works specifically in active finding of TB patients taking up an evaluator role within the Stop TB Partnership and cooperating with the Global Fund. He believes in the capacity of health care institutions and programmes to overcome the barriers preventing them to deliver realistically their health objectives even in difficult settings.

Dr Miranda Brouwer
Dr Miranda Brouwer is a public health medical doctor with over 20 years’ experience in clinical medicine and public health, and in supporting tuberculosis and HIV programmes. She is an analytical thinker with a practical approach to problem solving. She is able to make complex (medical) material understandable for all levels. She is a calm, flexible and reliable person with a good sense of humour, and focused to meet the objectives, and has strong abilities in planning, organising and monitoring.

Prof. Gihan El-Nahas
Prof. Gihan El-Nahas has worked on health policies including Ministries of Health, donor agencies, over 70 non-governmental organisations. Her role includes supporting strategic planning, foster policy change, advise on project management, developing capacity building and communication plans in developing countries. She has been a technical consultant on Bloomberg Initiative Grants programme; her role entailed reviewing plan development and monitoring implementation at country level. She has worked with the World Health Organization and several agencies on their grant proposals and grants project management. She has assisted several national programmes and technical advisory teams to develop health policy plans for assessment and monitoring.

Gayatri Sriram
An MBA from the University of Houston Texas, Gayatri is a certified coach and people development consultant to organisations since 2002, predominantly in the areas of leadership development, organisational growth and self-development. She is a specialist in interweaving self-awareness and empathic connections into larger interventions. As a facilitator she has worked with diverse participant groups of varied sizes, origins, functions and seniority levels in over seven countries. Gayatri has created programmes for leadership development, cross-cultural management, organisational visioning and change, personal effectiveness and self-awareness.

Dr Elizabeth Yarly
Dr Yarly is a dedicated advocate for individual interests within complex systems, bringing invaluable expertise in capacity development, coaching, and leadership enhancement. With a robust background as an Organizational Development consultant, she has successfully facilitated people-centered initiatives globally for over fifteen years. Her role as faculty focuses on crafting content that drives sustainable structural change, particularly in the domains of Global Health and Education.

Dr Irina Berezhnova
Dr Irina Berezhnova is a physician and public health professional with two decades of experience at regional and country level working with WHO, EU, USAID, DFID, GFATM, Bloomberg Initiative, NGOs, civil society and private sector. Dr Berezhnova has extensive experience in Monitoring and Evaluation of HIV and TB prevention programs in those regions by providing strategic oversight, and building capacity in performance and impact measurement. From 2009 until 2015 she served as Director of the Union Russia Office, developing and implementing Tobacco Control Programmes. Her professional interest is strategic consulting in public health, with a focus on tobacco control and non-communicable disease control.

Bartholomew J. Timm
Bartholomew J. Timm brings decades of experience to facilitating courses on Power and Influence, Networking and Partnerships. Bart is the owner and President of Timm & Associates, a management consulting firm he founded in 1987, and owner of www.TheBestResume.com, a website dedicated to helping both employers and employees in the hiring process. He is a cum laude graduate with departmental honours from Hiram College in Ohio, and earned an Executive MBA from the University of Notre Dame. He is a professional speaker, and a member of the Professional Speakers Association, and the Global Speakers Federation.
Individual Membership
Any interested individual may join The Union to support its international work and take advantage of the professional opportunities its worldwide network offers.
Student Membership
Any interested individual who is in training and under 35 may join The Union to support its international work and take advantage of the professional opportunities its worldwide network offers.
Benefactor Membership
Any interested individual who is able to make an additional contribution on top of their membership fee to support The Union.
Organisation Membership
Any organisation that shares the vision and goals of The Union may apply to become an organisation member
ARTICLE 5.3: CHALLENGES AND OPPORTUNITIES
subtitle: Wednesday 18 November
Article 5.3 in Framework Convention on Tobacco Control provides guidance to protect public health policies from the tobacco industry. This webinar will inform on the straties and challenges for implementing Article 5.3’s Guidelines, address approaches to strong implementation of the Convention and overcome the interference of the tobacco industry.
SMOKELESS TOBACCO: PREVALENCE, POLICY AND FUTURE CHALLENGE
subtitle: Thursday 26 November, 10:00 AM - 11:00 AM CET
Smokeless tobacco (SLT) users are exposed to a large and varied number of health hazards. It has been estimated that 90 percent of the world's SLT users live in the Southeast Asia region. This webinar will inform the latest research and policy developments on smokeless tobacco use in South Asia, and outline and discuss future challenges in controlling the smokeless tobacco demand and supply.
Transmission of M. tuberculosis in HIV prevalent settings
subtitle: Thursday 3 December, 3:00 PM - 4:00 PM CET
Speaker Leo Martinez, winner of the 2017 Stephen Lawn TB-HIV Research Leadership Prize, will provide an overview review of transmission dynamics of M. tuberculosis in settings where both tuberculosis and HIV are endemic.
Digital adherence technologies for tuberculosis: promise and peril
subtitle: Wednesday 16 December, 16:00 - 17:00 CET
Digital adherence technologies for TB are increasingly being used in a variety of contexts to monitor adherence to TB medications. This presentation aims to acquaint online attendees with the range of DATs being used in high and low TB burden settings.
Policy areas
The policy pages explain the rationale for, the challenges inherent in and the solutions for implementing and enforcing specific tobacco control policies—from smokefree (SF) to tobacco advertising at point-of-sale (POS) to tobacco vendor licensing (TVL).
Implementation Areas
The implementation area pages detail key elements of the implementation process. Find detailed guidance and best practice examples across all policy areas, from capacity building for inspectors to key elements of a strategic communication plan, to examples of compliance surveys, and more.
Meet the Experts
Use the experts page to find specialists in implementation and enforcement globally and in your setting.
Contact and Get Support
Find out more on how to get additional support through the programme.

Syed Mahbubul Alam
Syed Mahbubul Alam is a public health and environment policy lawyer who has worked on policy advocacy issues for over 19 years. Currently he works as a Technical Advisor for The Union, Bangladesh. Throughout his career, he has supported and led tobacco control law and policy development. He served as a legal expert on tobacco control law and policy, drafting committees of the Ministry of Healy and Family Welfare of Bangladesh. He holds an LLM from the World University of Bangladesh.

Tara Singh Bam
Dr Tara Singh Bam is the Regional Director for The Union Asia Pacific Office based in Singapore and a Technical Advisor for Tobacco Control for national and sub-national governments in Cambodia, Indonesia, Myanmar, Nepal, Timor-Leste, Malaysia, and the Philippines. He has more than 20 years of experience in tobacco control health policy development, implementation, research, and evaluation. Tara holds a Doctorate Degree in Health System Development and a Master of Public Health.

Diah Setyawati Dewanti
Dr Diah Setyawati Dewanti is a coordinator for The Union’s Global Implementation Programme in Indonesia. She works closely with sub-national governments, universities and civil society organisations to enforce smokefree policies and tobacco advertisement, promotion and sponsorship bans at point-of-sale. Diah holds a Doctorate Degree in Development Sciences and a Master in Economics of Health. Her research focuses on behavioural change evidence in youth smoking to support the development of comprehensive policy.
Khurram Hashmi
Khurram Hashmi is the Technical Advisor for The Unions Global Implementation Programme in Pakistan. He works closely with national and provincial governments and NGOs for policy development, implementation and capacity building of stakeholders in Pakistan. He is also the Pakistan focal point for Stopping Tobacco Organizations and Products (STOP), working to implement project activities and expand its related work on tobacco industry activity.

Connie Hoe
Dr Connie Hoe is an Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, International Health Department, Health Systems Programme. Her research focuses on the politics of the health policy process and utilises social science theories and methods to explore industry interference in public health policymaking, understand how international and national actors work collectively to advocate for national policy change/implementation, and examine factors that foster effective policy enforcement and increase policy compliance.

Anne Jones
Anne has been a Union Technical Advisor on tobacco control since 2007 following two decades as the CEO of the national advocacy organisation ASH Australia. She has worked internationally in China, Philippines and Vietnam on enforcement policies and helped to develop numerous resources and toolkits for smokefree laws, child rights, protecting health policies from tobacco industry interference and sustainable funding for tobacco control implementation and enforcement.

Ryan David Kennedy
Dr Ryan David Kennedy, PhD, is a tobacco control researcher and Associate Professor at Johns Hopkins Bloomberg School of Public Health. Ryan works in low- and middle-income countries through his role with the Institute for Global Tobacco Control and focuses his research on tobacco advertising at the point-of-sale, health warning labels, and clean air laws. Additionally, Ryan oversees a global policy scan to understand how countries/jurisdictions are regulating emerging nicotine delivery systems.

Dafei Li
Dafei Li is a coordinator for the Global Implementation Programme in China, focusing on tobacco control policy implementation and enforcement. He provides technical support to local partners to help Chinese cities build sustainable and robust tobacco control policy implementation mechanisms. Previously working with the Global Fund China, he brings years of international health development programme management experience to The Union.

Ashish Kumar Pandey
Bringing 20 years of progressive experience to The Union, Ashish Kumar Pandey currently works as a Deputy Director of Tobacco Control department of The Union. Pandey works closely with the country teams in India, Bangladesh, and Pakistan to reduce tobacco use. He has experience developing and implementing various tobacco control policies including smokefree, TAPS, protection of minors, graphic health warning, vendor licensing and tobacco industry monitoring.

Nidhi Sejpal Pouranik
Dr Nidhi Sejpal Pouranik is the Senior Technical Advisor of Tobacco Control for the Global Implementation Programme in India. She works in close coordination with the government, NGOs, local partners and civil society organisations to advance tobacco control initiatives at national and subnational level. She is the focal point for strengthening implementation and enforcement of TAPS bans, with a specific focus on point-of-sale through tobacco vendor licensing.

Gan Quan
Dr Gan Quan is the Director of Tobacco Control at The Union, leading the Tobacco Control Programme that operates in more than 20 countries. Gan Quan joined The Union in 2009 as a Technical Advisor and was the Director of The Union’s China Office from 2014 to 2016. He was closely involved in providing technical support to cities in China in both smoke-free law adoption and implementation. Gan Quan holds a PhD and an MS degree in Environmental Health Sciences from the School of Public Health, University of California.

Rana Jugdeep Singh
Dr Rana Jugdeep Singh has over 25 years of experience in public health at sub-national, national and international level. Rana Singh is currently Deputy Regional Director of Southeast Asia where he leads the Tobacco and NCD control programmes at The Union. He supports policy development and implementation, enforcement of legislations, capacity building of stakeholders, establishing networks and partnerships, and policy focused research.

Xiaojing Wang
Xiaojing Wang joined The Union in 2015 working on tobacco control and road safety programmes and is the Deputy Director of Tobacco Control of the Vital Strategies Jinan Representative Office, China. She received a Master of Public Administration from the Rockefeller College of Public Affairs and Policy at SUNY-Albany and a Bachelor of Arts from Capital Normal University.

Kathy Wright
Kathy Wright is the Programme Manager of the Global Implementation Programme and Global Hub, building and supporting a network of in-country experts who provide guidance and resources to city governments on implementation and enforcement of tobacco control policies. She brings over 11 years of international experience in project management, operations and network building to the programme.
Tobacco Atlas
The Tobacco Atlas is a resource to help understand the reality of the damage that tobacco causes and the evidence-based tools to address this.
1. Review the provisions of the law and associated regulations, preferably with a legal expert
Review of the authorities and responsibilities outlined in the law: which stakeholders have been assigned responsibilities and what authority do they have? It is important to review all related laws and regulations which impact the one being enforced. Identify potential challenges or gaps in the legal framework.
2. Identify any supporting data, ideally for the specific jurisdiction.
Examples of data include compliance levels, prevalence, usage, public attitudes to the law and to tobacco control. It is also helpful to establish the numbers of venues or businesses in operation. If none is available, consider conducting an assessment or mapping survey.
3. Map out all stakeholders in implementation and enforcement of the law.
Conduct a desk review and map out all key stakeholders. Identify other national or sub-national strategies that could be aligned with.
4. Consult with stakeholders
Conduct interviews with relevant stakeholders to assess: their support for implementation or potential to disrupt it; their level of influence; their motivations; challenges or gaps they identify in implementing and enforcing the law.
5. Explore other well-enforced laws
Learning from other sectors with successful and effective law enforcement can help inform planning and resourcing required for implementing the tobacco control law.
6. Analyse all available data to inform strategic plan
Conduct a gap analysis and identify priorities. Mobilise key stakeholders as part of the strategic planning and ensure buy-in. Make recommendations for amendments to law/regulations where appropriate.

Smokefree
For smokefree, the primary duty of compliance should ideally lie with venue owners or managers rather than individual smokers. Regulations should clearly outline managers’ responsibilities.

Tobacco Advertising, Promotion and Sponsorship
For TAPS regulations, responsibilities need to be assigned to a wide range of entities due to the number of different actors involved in advertising, promotion and sponsorship across all potential channels.

Packaging and labelling
For packaging and labelling of tobacco products, manufacturers, importers, wholesalers and retail establishments that sell tobacco products should bear legal responsibility for compliance with packaging and labelling measures and their associated costs, within specified time limits.

Tobacco Vendor Licensing
Well drafted vendor licensing regulations should ensure vendors comply with existing standing tobacco control regulations. They can also introduce stronger restrictions.
Bloomberg Initiative to Reduce Tobacco Use Grants Program
Bloomberg Initiative to Reduce Tobacco Use Grants ProgramBloomberg Initiative to Reduce Tobacco Use Grants ProgramBloomberg Initiative to Reduce Tobacco Use Grants ProgramBloomberg Initiative to Reduce Tobacco Use Grants Program
Tobacco Control enforcement and implementation webinar
subtitle: Wednesday 24 February, 13:00 – 14:30 CET
Hear from tobacco control implementation experts who share their experiences of achieving high compliance with tobacco control laws, through real-world case studies, and learn how to use these experiences to improve compliance rates.
Carrie Tudor
(United States of America), Chair, Coordinating Committee of Scientific Activities

Tara Singh Bam
subtitle: Director, The Union Asia Pacific Office
Tara Singh Bam has 25 years’ experience in policy development, programme management, research and evaluation in tuberculosis and tobacco control, prevention of non-communicable diseases (NCDs) and health system strengthening across Asia Pacific. The WHO Director-General nominated him as a member for the WHO Civil Society Working Group on NCD. He holds Master degree in Public Health and Doctorate Degree in Health System Development.

Aissa Aridj
subtitle: Chief Financial Officer
Aissa Aridj brings over 20 years of finance experience to his work at The Union.

Marta Budziak
subtitle: Head of The Union Edinburgh Office
Marta has been working for The Union since 2007. Marta oversees the management of The Union Edinburgh Office and the day-to-day running operations. She has played an important role in the growth of the tobacco control activities, providing advice and support to the technical departments, and building strong relations with donors. Marta is also Project Controller for Bloomberg Tobacco Control projects of The Union and works closely with the finance and technical department teams as well as the regional and country offices on tobacco control projects.

Charlotte O'Sullivan
subtitle: Director, The Union Myanmar Office
Charlotte O'Sullivan has been working with The Union since 2017, bringing more than 20 years’ experience in the development of health services in reproductive health, nutrition, maternal and child health, systems strengthening, TB and HIV. She provides leadership and strategic direction of The Union’s regional and global health programmes in Myanmar.

Dr Kuldeep Singh Sachdeva
subtitle: Director, The Union South East-Asia Office
Dr Kuldeep Singh Sachdeva is a medical doctor (MBBS) with over 32 years’ professional experience within the Indian government health system. He provides leadership and management to all Union programme activities of the South-East Asia Office.
Throughout his career, he has played an important role in strengthening health systems, promoting Public-Private Mix in tuberculosis (TB) Control, supporting TB collaborative activities with HIV, Tobacco, Diabetes, Paediatric TB, and the scaling up of programmatic management of drug resistant TB.

1st Prize

2nd Prize

3rd Prize

HONG KONG TUBERCULOSIS, CHEST & HEART DISEASES ASSOCIATION

3rd Prize

2nd Prize

PHILIPPINE TUBERCULOSIS SOCIETY INC.

1st Prize

Bernadette Fellarika Nusarrivera
Bernadette Fellarika Nusarrivera is the Program Coordinator for The Union's Global Implementation Programme in Indonesia, managing efforts in 5 expansion cities and working closely with subnational governments and local partner organizations. Fella has robust experience assisting local governments on the development and implementation of 100% smokefree policies, tobacco advertising bans, and regional tobacco taxations.

Dr Rebecca Lin
Rebecca Chou-Jui Lin is a pulmonologist working in Taoyuan General Hospital, Ministry of Health and Welfare and one of the lead physician of the five MDRTB teams in Taiwan. She had also participated in the DRTB workshop and technical assistance in Vietnam and the Philippines. Over the years, her patients had taught her how to appreciate simple but important things in life: a genuine smile, a few kind words, and a cup of good coffee, from which we can all find courage to move on.

Dr Bolormaa Sukhbaatar
Technical Officer, World Health Organization

Cyril Alexander
Executive Director of the MARY ANNE Charity Trust (MACT)

Jianshu Zhang
President of the Beijing Tobacco Control Association

Dr Nandita Murukutla
Vice President of Global Policy and Research, Vital Strategies
1. 与法律专业人士一起,检视法律条款和相关法规
检视法律法规中各部门的权责,包括哪些相关部门、机构对应哪些权利和责任,同时有必要检视所有可能影响到控烟法规实施的其他相关法律法规,了解在现有法律框架下的潜在挑战和不足。
2. 明确政策实施地区的相关支持性数据
相关数据包括法律遵守水平、烟草流行率及使用情况、公众对控烟及控烟法律的态度,以及各类场所的数量等。如果上述数据均缺乏,建议考虑开展评估或摸底调查。
3. 列明法律实施和执法工作的所有利益相关方
通过开展案头研究列明所有利益相关方,发掘其他可以撬动的国家级和省级的相关政策和策略。
4. 征求利益相关方的意见
开展与各利益相关方的访谈,了解他们对法律实施的支持或潜在的负面影响、他们的影响力和动机,以及从他们的角度观察到哪些实施和执法的挑战和差距。
5. 借鉴其他成功实施的法律法规
学习其他领域中政策法规成功实施的经验有助于为控烟法律法规实施的规划和资源获取提供信息和借鉴。
6. 分析相关数据以支持战略规划
进行差距分析并确定工作优先级。动员关键的利益相关方参与到战略规划的制定并争取其支持。适时、酌情提出修改法律法规的建议。

Dr Kobto Ghislain Koura
subtitle: Director, Department of Tuberculosis
Kobto is a Medical Doctor Public Health Specialist. Since joining The Union in 2013, he has addressed the challenges of tuberculosis (TB) by supporting National Tuberculosis Programmes. This involves planning, designing, implementing, monitoring and evaluating strategies and policies for the prevention, detection and management of drug-susceptible TB, multidrug resistant TB in adults and children. Dr Koura’s other work includes operational research projects, participating in Union training courses and providing technical assistance.

Ir. H. Imam Budi Hartono
subtitle: Vice Mayor of Depok City, Indonesia
Imam Budi Hartono is the Vice Mayor of Depok city, Indonesia. He graduated from Faculty of Engineering, University of Indonesia in Petrochemical Gas and currently working towards his masters degree in Urban Development. He started his political career at 31 years old as a member of parliament for 2 period. In 2021 he was elected as the Vice Mayor of Depok, the Jakarta greater area city with 2 million populations. Under his leadership, he strengthens the health system and health infrastructure including advancing smokefree regulations and strengthening the taskforce and implementation on smokefree, tobacco advertising, promotion, and sponsorship ban including ban tobacco product display at the point of sale.

Sandra Marques
subtitle: Technical Director of Health at the Reference Center for Alcohol, Tobacco and Other Drugs-CRATOD, Sao Paulo
Sandra Marques is the Technical Director of Health at the Reference Center for Alcohol, Tobacco and Other Drugs-CRATOD, acting as State Coordinator of the Tobacco Control Program linked to the National Cancer Institute - Ministry of Health. She is a member of the State Committee for Social Control of Tuberculosis – SP and a member of the GEPRAPS (Group of Study and Respiratory Research in Primary Health Care) of the ABC Medical School. Sandra is also a Dental Surgeon, specializing in Chemical Dependence-UNIFESP and currently a master's student in Public Health Surveillance at CCD/SESSP. She is also a collaborating member of the Respiratory Diseases Group of the Brazilian Society of Medicine and Family - GRESP/SBMFC.

Dr. Hafsa Lukwata Sentongo
subtitle: Assistant Commissioner Mental Health and control of Substance Use, Kampala
Dr. Hafsa Lukwata Sentongo is a medical doctor, MBChB (Mbarara Univ. of Science and Technology; MUST 1997), with a Post Graduate Diploma in Research in Tropical Medicine (Nagasaki University Japan 2003), Post Graduate training in Demography and population studies (Makerere University 2005) as well as a Master’s degree in Public Health (Makerere Univ Kampala 2018). She is currently the Acting Assistant Commissioner Health Services; Mental Health and Control of Substance Abuse Division, Non-Communicable Diseases Department, Ministry of Health Headquarters. Have worked in the Ministry of Health since 2005 having previously worked with Infectious Disease Institute (Pediatrics) Mulago Hospital as a senior Medical Officer and Mengo Hospital as a Medical Officer. She is the National Mental Health and Psychosocial Support (MHPSS) team leader during emergencies and epidemics. Tobacco Control focal person and a Team lead for the Alcohol control (SAFER) initiative and focuses on work with policy formulation, in relation to Mental Health, Tobacco Control and Alcohol and Drug Abuse and focuses on research in mental health, tobacco control, and alcohol use among young people in Uganda.

Lara Garrido
subtitle: Director, Training & Education
Lara has been part of the Training and Education Department since 2016, leading the design, development and delivery of face-to-face and online trainings. Prior to joining The Union, Lara advocated for better health policies in Europe and provided public relations advice to multinational organisations in South Africa.

Zahedul Islam, Chair and Europe Representative
Zahedul is Director of Treatment, Procurement and Supply Management at Alliance for Public Health – Ukraine. For over 15 years, Zahedul worked with Medecins Sans Frontieres in West and Central Africa, India, Central Asia and Eastern Europe in positions including Head of Mission and Country Director. He has an MBA in Public Health Management. He is a civil society representative on the WHO Access to COVID-19 Tools Accelerator platform, executive committee member of STOP TB Partnership Ukraine and a member of Medecins Sans Frontieres - South Asia board of directors.

Tariro Kutadza, Africa Representative
Tariro Kutadza is an HIV/TB Advocate with ZNNP+ based in Zimbabwe. A former teacher, she is known as a community actor working for the improvement of the community to HIV and AIDS response in Southern Africa.
Tariro has been a Union member since 2013. She is an active trainer and facilitator on HIV/TB prevention and treatment. Tariro has an Honours in Educational Management and a Master’s in Public Health.

Eva Naznin, Asia Pacific Representative
Eva has 10 years of experience in public health, health care financing, health systems strengthening, policy analysis, primary healthcare, and implementation support.
Eva has worked for several international organisations, including Campaign for Tobacco Free Kids, World Health Organization, and International Centre for Diarrhoeal Disease Research. She has a PhD in Community Medicine and Clinical Epidemiology and a Master’s in Health Economics in the field of health and development.

Priyanka Aiyer, South East Asia Representative
Priyanka Aiyer is a communications specialist with over seven years of experience in designing and implementing campaigns at national, regional and global levels. Priyanka was the Communications and Digital Media Officer at the Global Coalition of TB Advocates.
She regularly workers with patient rights groups, survivor coalitions and community members at large.
Priyanka is the co-author of the Asia Pacific TB and Human Rights Advocacy Strategy, and she has curated the collection of survivor stories - Men and TB Stigma: Conversations of Resilience in The War Against TB. She has a Master's in film studies.

Ajaz Akhtar, Affected Community Representative
Dr Ajaz Akhtar is an experienced medical practitioner with clinical specialisation in family medicine. He has a Master’s in public health and a PhD in social science.
Ajaz is from Pakistan, where the population is highly affected with chronic pulmonary diseases such as TB, bronchial asthma, chronic obstructive pulmonary diseases. He is working to best tackle the needs of affected communities and civil society.

Erman Varella, Affected Community Representative
Erman Varella is Program Manager at Stop TB Partnership Indonesia.
Erman has 15 years’ experience in HIV and TB programmes, with a focus on: advocacy, communication and social mobilisation, community engagement; capacity building of social workers and civil society organisations, peer support, TB active case-finding, motivational interviewing, proposal development, case management and psychosocial support.

Phumeza Tisile, Affected Community Representative
Phumeza Tisile is a health activist, a student at the University of Cape Town and an advocacy officer at TB Proof.
In 2010, she was diagnosed with normal TB, while all along she had extensively drug-resistant TB. Phumeza went through gruelling treatment that left her deaf in both ears. In 2015, she got a once in a lifetime chance to hear again. She can hear now using cochlear implants.
Phumeza co-authored the first Drug Resistant TB Manifesto, which she presented at the 67th World Health Assembly.

Kinz ul Eman, Middle East Representative
Kinz ul Eman is a global health professional, chartered accountant, and project management expert. Kinz is currently leading Dopasi Foundation's programmatic interventions across Pakistan. She has worked in various national and international consulting assignments with the World Bank, Stop TB Partnership, Jhpiego and various UN agencies.
Kinz is the pioneer of the TB Community, Rights and Gender Action Plan 2023-25 in Pakistan. She is the secretarial lead for Stop TB Partnership Pakistan, the End TB Parliamentary Caucus and TB survivors’ group in Pakistan.

Prof Christoph Lange
Secretary General
Prof Christoph Lange is a pulmonologist and infectious diseases specialist. He is the Medical Director of the Research Centre Borstel, Leibniz Lung Centre, Professor of Respiratory Medicine & International Health at the University of Lübeck, Germany, and Head of the Clinical Tuberculosis Unit of the German Centre for Infection Research.
His broad research interests include the epidemiology, prevention, diagnosis and treatment of tuberculosis, as well as implementation of research findings into clinical practice. He is the founding Chairman of the Tuberculosis Network European Trials Group.
He is one of the clinical leads of the UNITE4TB project, an EU-funded international clinical trials platform for the evaluation of novel anti-tuberculosis medicines operating in Europe, Africa, Asia and South America.

Dr Syed Karam Shah
Dr Syed Karam Shah is an expert in tuberculosis control. In 2000, he was appointed as the first National Manager of Pakistan’s Tuberculosis Control Program.
From 2006-2014, he led the WHO TB Control team in Afghanistan. He went on to be WHO Medical Officer in the Eastern Mediterranean Region, assisting 22 countries in planning and implementing the End TB strategy. He was also the coordinator for the Global Fund for Easter Mediterranean Region.
Since 2016, he has been working as Adviser for Communicable Diseases Control in the Ministry of National Health Services, Regulations and Coordination in Pakistan. He has also been leading new initiatives to End TB.
Syed is also a Senior Adviser for Stop TB Partnership Pakistan, has authored several research publications and received the Princess Chichibu Award. He is also a former President of the Pakistan Chest Society.

Dr Ikushi Onozaki
Dr Ikushi Onozaki is a public health expert as well as a trained physician on respiratory medicine. He is executive adviser at the Japan Anti-TB Association (JATA) and has been an individual member of The Union for more than 30 years.
He has rich experiences in TB care and prevention in TB high-burden countries, assisting national tuberculosis programmes to expand TB service to peripheral and/or marginalised populations.
Ikushi is also a pioneer in implementing TB prevalence surveys and active case detection in resource limited settings. He led the prevalence survey group of the WHO Global Task Force on TB Impact Measurement from 2007 to 2016 to conduct surveys in more than 20 countries in Asia and Africa. He re-joined JATA as a staff member in 2020.

Evaline Kibuchi
Evaline Kibuchi is a global health advocate with over 15 years' experience. Currently she is the Chief National Coordinator at Stop TB Partnership Kenya and a member of the Civil Society Task Force at the WHO TB team.
Evaline expertise include engaging political leadership and working with media, civil society and the infected and affected communities in TB and lung health.
She holds a Bachelor of Arts and a Post Graduate Diploma in Mass Communications from the University of Nairobi and is completing a Masters of Public Health at Moi University.
She is the Chair of the Board of WACI Health and a board member of Aids Health Care in Kenya.

Dr Stephen John
Dr Stephen John has been active in TB, Leprosy and HIV control in Nigeria since 2003, having served as a TB Programme Manager and an HIV Agency Executive Secretary. Stephen is currently a Health Ministry Director of Planning, Research and Statistics.
Stephen has served as a trainer at the National TB and Leprosy Training Center Zaria, Nigeria, a mentor to State TB and Leprosy Programme Managers and a university teacher. He has been a consultant for several organisations and is presently serving as a technical consultant to the United Nations Office for Project Services.
His interest in TB control among key, vulnerable and underserved populations in North East Nigeria has grown over the years.
Stephen is a graduate of Medicine, has a Master of Public Health/International Course in Health Development and a has Professional Diploma in Education.

Dr Edward Nardell
Dr Edward Nardell is a Professor of Medicine and Public Health, and Associate Physician at Brigham & Women’s Hospital, USA.
Edward's early career as a pulmonologist at Cambridge Hospital, with an academic focus on tuberculosis, saw him become TB Control Officer. In the early 80s TB outbreaks in a large homeless shelter and a Boston Welfare Office led to a career-long interest in airborne infection, TB in particular, and air disinfection by ventilation, room air cleaners, and germicidal UV.
In 2005 he delved into global TB control in Dr Paul Farmer’s Division of Global Health at Brigham & Woman’s Hospital, to guide MDR-TB treatment in Peru and Russia, and to pursue TB transmission research in a human-to-guinea pig transmission facility in South Africa. At the same time, he headed a Fogarty research training program focused on airborne transmission.
Most recently he has been engaged in Covid-19 transmission research, responding to increased demand for germicidal UV research, including converting the South African facility into a human-to-hamster Covid-19 transmission facility unit to test a variety of interventions.

Tyler Dimich
subtitle: Head of Membership
Tyler has an extensive background in membership management, customer service and project development.
Throughout his career, he has worked to improve the member experience, and he brings a wealth of not-for-profit and charity management knowledge to The Union.
For any membership, scientific section, sub section or working group related queries, please email membership@theunion.org.

Alex Metcalfe
subtitle: Head of Communications
Alex is a communications professional with public and private sector experience.
He worked in the UK National Health Service for several years - from hospitals to the national research body - before moving to healthcare communications agencies. Alex has led national and global healthcare awareness campaigns.
Prior to joining The Union, he was the Research Communications Manager at Guy's and St Thomas' NHS Foundation Trust, London. Alex has a masters in journalism (web).

Sanhita Sinha
subtitle: Chief Human Resources Officer
Sanhita has been with The Union since 2020.
Sanhita has nearly 22 years of experience working in the field of human resources with reputable corporates and international NGOs. In her current role, Sanhita is responsible for leading The Union's overall human resources strategy and management.
She is a postgraduate in comparative literature and human resources.

An Nguyen
Dr. An Nguyen serves as the Union's technical officer in Vietnam for the Global Implementation Program. She has more than 20 years of experience working in the fields of research, social work, education, health, and communication. She has five years’ experience working in tobacco control from her time at Health Bridge Canada. Dr. Nguyen holds a Doctor and Masters degree in Sociology Science from the University of Social Science and Humanities, Vietnam.

Ray Wang
Rui (Ray) Wang is the Director of Tobacco Control of the Vital Strategies Jinan Representative Office, China. Ray has more than 10 years of managing experience at health promotion non-government organizations and 7 years of working experience as a resident diplomat. Ray has a Master of Science degree in Global Health from Duke University and a bachelor’s degree in economics from the China Foreign Affairs University.

Amie Liu
Amie Liu is a tobacco control program coordinator for Vital Strategies Jinan Representative Office in China. She is the focal point for strengthening implementation and enforcement of smokefree regulations in Lanzhou and Qingdao cities and works closely with municipal governments. She is also the focal point for Stopping Tobacco Organizations and Products (STOP) in China, working on monitoring the tobacco industry’s activities.

Ashish Kumar Pandey
subtitle: Deputy Director of Tobacco Control, The Union
Bringing 20 years of progressive experience to The Union, Ashish Kumar Pandey currently works as a Deputy Director of Tobacco Control department of The Union. Pandey works closely with the country teams in India, Bangladesh, and Pakistan to reduce tobacco use. He has experience developing and implementing various tobacco control policies including smokefree, TAPS, protection of minors, graphic health warning, vendor licensing and tobacco industry monitoring.

Dr Ryan David Kennedy, PhD
subtitle: Tobacco Control Researcher and Associate Professor, Johns Hopkins Bloomberg School of Public Health
Dr Ryan David Kennedy, PhD, is a tobacco control researcher and Associate Professor at Johns Hopkins Bloomberg School of Public Health. Ryan works in low- and middle-income countries through his role with the Institute for Global Tobacco Control and focuses his research on tobacco advertising at the point-of-sale, health warning labels, and clean air laws. Additionally, Ryan oversees a global policy scan to understand how countries/jurisdictions are regulating emerging nicotine delivery systems.

Dmytro Kupyra
subtitle: Executive Director, NGO Advocacy Center LIFE
Dmytro Kupyra is the Executive Director of the NGO Advocacy Center LIFE. Dmytro has been a leader in the advocacy of anti-tobacco legislation in Ukraine since 2009, with vast experience in advocating and advancing legislation and implementing tobacco control projects both for NGOs and the Public Health Center of the Ministry of Health of Ukraine.

A K M Maksud
subtitle: Executive Director, Grambangla Unnayan Committee
A K M Maksud is involved in programs and research for social development since 1993 with Grambangla Unnayan Committee, an NGO working in Bangladesh especially in tobacco control, public health, primary and technical education, child labour etc. Maksud obtained his Bachelor of Laws degree from the University of London and obtained a Master’s degree in Sociology from the University of Dhaka. Maksud has innovated a unique online surveillance system for collection and processing on data in relation to 10,000 tobacco POS and TAPS violation.

Ms Qi Fei
subtitle: Director, Health Education and Promotion Department, Qingdao Municipal Center for Disease Control and Prevention
Qi Fei is the director of the Health Education and Promotion department at the Qingdao Municipal Center for Disease Control and Prevention. Dr. Qi Fei is a chief physician and a graduate supervisor in the School of Public Health at Peking University, Shandong University, and Qingdao University. She is also actively involved in healthy cities programs and patriotic health management in Shangdong Province and Qingdao. Qi Fei has extensive experience in the promotion of national health programs and health literacy.
Mr Rajiv Singh
subtitle: State Tobacco Control Cell Consultant, Jharkhand
Mr. Rajiv Kumar is the State Consultant in the National Tobacco Control Programme (NTCP) under the Ministry of Health in Jharkhand. He currently provides technical and program management support for the implementation of the Jharkhand NTCP. His support contributed to the implementation of India’s first state-level Tobacco Vendor Licensing policy, with a special focus on TAPS compliance at the point of sale. Mr. Kumar has over 12 years of experience in tobacco control in Jharkhand.

Ms. Umamah Solangi
subtitle: (PAS), Assistant Commissioner, Ferozabad Karachi East
Ms. Umamah Solangi is the Assistant Commissioner Ferozabad (Sub-division) of Karachi East for the Pakistan Administrative Service. She previously served as the Additional Deputy Commissioner / Head Tobacco Control Cell and District Implementation and Monitoring Committee on Tobacco Control in the same District. She had organized various activities regarding tobacco control laws and tobacco use hazards awareness among youth, and also did efforts for the strict enforcement of tobacco control laws at public places.

Drs. Supian Suri MM
subtitle: City Secretary, Depok City
Supian Suri serves as the City Secretary of Depok city, Indonesia. He currently leads the city’s smokefree taskforce team, which is dedicated to strengthening implementation of smokefree and TAPS regulations. Supian Suri works closely with local and international stakeholders to improve implementation and share valuable lessons learned and best practices with other cities across Indonesia. He holds a degree from Institute of Home Affairs Governance and is currently pursuing his doctoral degree in government studies.

Kelland Stevenson
subtitle: Director, The Union Myanmar Office
For over 35 years Kelland have been working as an international development and humanitarian professional in Africa and Asia. He brings extensive experience from working on health, education and environmental programs during his career.
In addition, he has over a decade of working experience in Myanmar. Kelland also has a wealth of experience in team-building, strategic thinking, and program management. He also holds a Master’s in Land Use Planning.

Prof Justin Denholm
subtitle: Co-Chair
Professor Justin Denholm is an infectious diseases physician based at the Royal Melbourne Hospital, Australia, and the Medical Director of the Victorian Tuberculosis Program.
His work includes clinical and public health management of TB and other infectious diseases, as well as research into a variety of aspects of TB relating to ethics, epidemiology, clinical medicine and public health. Justin has an active research program in ethical issues related to TB in society, including public health policy, screening programs and isolation.
Justin has been a member of the Ethics Advisory Group since 2012 and Chair since 2018.

Dr Sharon Nisha Biribo
Ms. Sharon Biribo is a Lecturer at the Umanand Prasad School of Medicine and Health Sciences at the University of Fiji. Her work includes teaching within the MBBS, Bachelor of Medical and Health Sciences, Bachelor of Public Health Programmes and supporting research and capacity development at the School and local Health Research Ethics Committees.
Sharon teaches courses in Clinical Microbiology, Infectious Disease Surveillance & Outbreak investigations, Epidemiology, Biostatistics and Research. She is actively involved in national and regional Research Capacity Building activities and is passionate about improving Research Ethics Approvals processes in Pacific Island Countries.
Sharon has been a member of the EAG since 2022.

Dr Lynette Keneilwe Mabote Eyde
Lynette Keneilwe Mabote Eyde has over 15 years of experience designing macro- and micro-level human rights and gender-affirming health systems and enabling environments for communicable and non-communicable diseases in Africa, Latin America and South-East Asia. She is the global Advocacy Advisor for the Treatment Action Group
Lynette has an extensive quantitative and qualitative research background in areas of Intellectual Property Rights-barriers, new technologies, including long-acting technologies, biologics and the use of technologies. She is part of the Africa Diagnostics Network aimed at mobilising local production for point-of-care diagnostics.
Lynette represents NGOs on the Unitaid Board. She is a Taskforce member of the Global Oxygen Alliance and on the Advisory Committee of the "Global Health Multi-stakeholder Dialogue: From Hiroshima to Puglia".

Dr Razia Fatima
subtitle: Co-Chair
Dr Razia Fatima is currently the Chief of Research & Surveillance at The Common Unit to Manage TB, AIDS and Malaria Pakistan with 19 years of diverse public health experience.
She is a medical doctor, has a PhD in Public Health from the University of Bergen, Norway and M.Sc. Epidemiology from the London School of Hygiene and Tropical Medicine, UK. She had led the international Structured Operational Research Training Initiative in Pakistan since 2016. She has published approximately 65 research papers in international peer reviewed journals. In 2024, she was awarded The Union Medal for TB.

Dr Alwyn Mwinga
Dr Alwyn Mwinga is a physician with a special interest in TB, HIV, and bioethics. Alwyn served a member of the University of Zambia Ethics Committee for 10 years and is currently a member of the Research for Ethical Data Science in Sub-Saharan Africa.
Alwyn is currently a member of the Board of the Drugs for Neglected Diseases Initiative as a patient representative. She served as Associate Editor for the International Journal of Tuberculosis and Lung Diseases for 10 years.
Alwyn has served as external reviewer for research proposals with various international organisations, a member of the Data Safety Monitoring Committee and Trial Steering Committees for several clinical trials and as a member of TDR Scientific Working Group for Research Capacity Strengthening and Knowledge Management.
Alwyn is the Chairperson for the Ministry of Health’s Tuberculosis Technical Working Group. She is the Chief Executive Officer for Zambart, an independent research organization based in Zambia.

Mr Apurva Narain
Apurva Narain is an independent consultant in international development, with a focus on public health, ethics and ecology.
He has multidisciplinary interests and around 30 years of combined experience in the social, corporate and academic sectors. A member of the Ethics Advisory Group since 2012, Apurva co-started its regional education outreach and was the Vice-Chair during 2018-21.
He was also a consultant with The Union South-East Asia Office during 2009-13 in the areas of strategy and communications. He is based in New Delhi.

Prof Nesri Padayatchi
Professor Nesri Padayatchi is a scientist, clinician and epidemiologist in Durban, South Africa at CAPRISA, and is affiliated with the Department of Community Medicine at the University of KwaZulu-Natal Nelson Mandela School of Medicine.
Nesri has over 35 years clinical and research experience in quantitative and qualitative HIV-TB and clinical trials, both self-initiated and international network related. She has 142 publications in peer-reviewed journals including the NEJM and Lancet.
Nesri serves on various Scientific Advisory Boards and Data Safety Monitoring Boards, and has a particular interest in mentoring the next generation of scientists.

Dr Karuna D Sagili
subtitle: Vice Chair
Dr Karuna D Sagili is a public health researcher based in New Delhi, India. Karuna previously served The Union South East Asia (USEA) Office for over 11 years in various capacities, including being Chair of the Technical Advisory Group and leading the development of USEA’s five-year organisational strategy.
Karuna's focus is on health system strengthening for infectious diseases and neglected tropical diseases. She is an expert in Operational Research and Systematic Reviews. She has published about 60 scientific research publications in international and national peer reviewed journals. Her research on stigma contributed to the National End TB Stigma Strategy adopted by the National TB Elimination Program, whose development she also supported as a technical working group member.
Karuna has been associated with the EAG since 2013.

Dr Diego Steven Silva
Dr Diego Silva is a Senior Lecturer in Bioethics at Sydney Health Ethics and the School of Public Health, University of Sydney, Australia.
His research centres on public health ethics, particularly the application of political theory in the context of infectious diseases and health security, e.g. tuberculosis, COVID-19 and antimicrobial resistance.
Diego has been a member of the EAG since 2022.

Dr Stephen John
Dr Stephen John has been active in TB, Leprosy and HIV control in Nigeria since 2003, having served as a TB Programme Manager and an HIV Agency Executive Secretary. Stephen is currently a Health Ministry Director of Planning, Research and Statistics. Stephen has served as a trainer at the National TB and Leprosy Training Center Zaria, Nigeria, a mentor to State TB and Leprosy Programme Managers and a university teacher. He has been a consultant for several organisations and is presently serving as a technical consultant to the United Nations Office for Project Services.
Stephen is a graduate of Medicine, has a Master of Public Health/International Course in Health Development and a has Professional Diploma in Education. Dr Jhon serves as a member of the Board of Directors of The Union.

Dr Tara Bouton
Dr. Tara C. Bouton is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine of Boston University and an attending physician in the Section of Infectious Diseases at Boston Medical Center. Dr. Bouton’s research focuses on the impact of HIV infection and substance use on evolution and transmission of drug resistant tuberculosis and improving outcomes in these diseases. She is also working to better understand transmission and viral dynamics of SARS-CoV-2 variants. She has lived and worked in Brazil, Ghana, Botswana, and South Africa.

Sheilla Chebore
Sheilla Chebore has a master's degree in medical microbiology and is currently doing a PhD. Sheilla has over 20 years’ experience in the field of laboratory science, working in diagnostic clinical settings, research settings and public health programmatic settings both in public, international agencies and non-profit organizations. Sheilla also has over 10 years’ experience in public health programmatic settings with extensive knowledge in TB, HIV, AMR and COVID 19 laboratory diagnostics. She has supported and consulted for the Kenyan National Tuberculosis Lung and Disease Programme (NTLD-P) and national public health laboratories.

Nqobile Mlilo
Nqobile Mlilo is the monitoring and evaluation specialist at The Union Zimbabwe Trust. He provides technical support to the Zimbabwe National TB Control Program and has been working in the field of public health monitoring and evaluation of TB/HIV programs for 19 years.

Dr Pranay Sinha
Dr Pranay Sinha is an Infectious Diseases physician and an Assistant Professor of Medicine at Boston University. He has been involved in TB research since 2014 and his primary interest is in the relationship between undernutrition and TB. Through epidemiological studies & health economic modelling, he hopes find ways to use nutritional policy to end TB. Dr Sinha has field experience in India, Benin, Togo, and South Africa.

Annika Sweetland
Annika Sweetland is a social worker and Assistant Professor of Clinical Sociomedical Sciences in Psychiatry at Columbia University College of Physicians and Surgeons/Mailman School of Public Health. She is also Co-Founder and Co-Chair of the TB and Mental Health Working Group at The Union. For the past 20 years, she has conducted global mental health work in Latin America, Africa and the United States, with a topical focus on TB and depression.
Dr Stella Zawedde-Muyanja
Stella Zawedde-Muyanja is a medical doctor and research scientist based at the Infectious Diseases Institute, College of Health Sciences, Makerere University, Uganda. Her primary research focus is implementation research to improve delivery of and access to TB care services. While working with the Union Uganda, she led the pilot implementation of a project to decentralize child TB services in Uganda (the DETECT Child TB project). Dr. Zawedde-Muyanja has worked with the Uganda NTLP on a number of initiatives to improve provision of TB care services.

Dr Ajay Kumar
Dr Ajay Kumar is a seasoned Public Health Practitioner with over 24 years of experience in low- and middle-income settings. He currently leads the Centre for Operational Research of the International Union Against Tuberculosis and Lung Disease. In the past, he has worked for WHO-India as a consultant for providing technical assistance to the Government of India’s National Tuberculosis Programme, particularly in leading TB-HIV co-ordination activities. He is an author/co-author of over 250 publications, with many contributing to a change in policy/practice and has facilitated over 100 national and international courses on operational research.

Dr Anthony D. Harries
Anthony David Harries is Senior Advisor at The Union and an honorary professor at the London School of Hygiene and Tropical Medicine in the UK. He is a physician and registered specialist in the UK in infectious diseases and tropical medicine. He spent over 20 years living and working in sub-Saharan Africa. His main interests are in the field of tuberculosis, HIV/AIDS, non-communicable diseases, tropical medicine and operational research.

Dr Divya Nair
Divya Nair is an Operational Research Fellow at The Union. She is a medical doctor with post graduate degree in Community Medicine. She has close to a decade’s experience of designing and managing community-based multi-site multi-partner research projects related to epidemiology, public health and policy research. She is trained in Good Clinical Practices and regulatory guidelines governing the ethical conduct of biomedical and clinical research in India.

Dr Pruthu Thekkur
Pruthu Thekkur is a Senior Operational Research Fellow at the Centre for Operational Research (COR) at The Union. He is a medical doctor with MD in Community Medicine. He has a decade’s experience in leading multiple operational research projects in collaboration with various national governments, research institutes, and international NGOs in the South-East Asia and Africa region. He is a senior mentor for Structured Operational Research Training Initiative (SORT IT) and has mentored about 50 public health professionals from more than 15 countries.

Collins Timire
Collins Timire is a Senior Operational Research Fellow at The Union, seconded to the National TB Programme, Zimbabwe. He recently completed a PhD at the London School of Hygiene & Tropical Medicine, UK. In addition, he holds a Master of Public Health and a Bachelor of Medical Laboratory Science. Collins is adept at both qualitative and quantitative research methods. Collins has more than 60 publications in peer reviewed journals, and is a recipient of the New Zealand Development Scholarship and the Fogarty Fellowship, National Institute of Health, USA.

Dr Mahalakshmy T
Dr Mahalakshmy T is a medical doctor and currently teaches at the Jawaharlal Institute of Postgraduate Medical Education and Research, in Puducherry, India. She has expertise in epidemiology, qualitative research, medical education research and operational research. She is pursuing her fellowship in Health Policy and Systems Research. She has around 10 years of experience in designing and mentoring public health research projects for MD and MPH students. Her areas of interest are cancer epidemiology, adolescent health and tuberculosis.

Yen Phan
subtitle: Chief Finance and Administration Officer
Yen Phan is a seasoned chief financial officer with a distinguished career spanning multiple industries and global regions. With extensive experience in financial leadership roles, she has consistently delivered stellar results through strategic planning, cost optimisation, and operational efficiency initiatives. From guiding start-ups through transformative shifts to steering multinational corporations towards sustainable growth, Yen's expertise in finance, coupled with her commitment to excellence, has earned her a reputation as a trusted advisor and driving force behind organisational success.

Nidhi Bansal
subtitle: Director, The Union India Office
Nidhi has worked extensively in India on pressing social development challenges and in several countries across Asia, Africa and North America on issues spanning health, education, livelihoods and humanitarian response. She joined The Union from her previous role as Director, Program Quality and Impact with CARE, Canada.
With 30 years of experience, Nidhi has had the unique opportunity of working within diverse socio-economic contexts, in organisations of differing scales and across management levels. Setting up and managing country offices is Nidhi’s speciality.

Dr Cassandra Kelly-Cirino
subtitle: Executive Director
Dr Cassandra Kelly-Cirino is a global health leader known for her extensive experience in infectious disease control and public health. With over two decades of work dedicated to improving health outcomes in low- and middle-income countries.
Before joining The Union, Cassandra has held several pivotal roles in various global health organisations.
Cassandra’s commitment to equity and innovation in health care has positioned her as a respected advocate for vulnerable populations disproportionately affected by communicable and non-communicable diseases.